Line segment worksheets

The reddit for online collaboration

2013.05.04 19:54 jbmach3 The reddit for online collaboration

Love to sing with other people? This reddit aims to put people together. Do the following to create a thread: 1. Create a text post 2. Post link to youtube video with audio 3. Post link to lyrics that match 4. State whether responses should be done line by line, by part, or other. 5. Post yourself singing the first segment and let 'er rip
[link]


2012.08.10 20:19 captapocalypse DC's Shazam / Captain Marvel / The Captain

This subreddit is NOT for the Shazam music app but for any and all conversations regarding the DC Comics character, Shazam. You may also know him as Captain Marvel or The Captain or simply Billy Batson. You may also discuss any and all related characters such as The Wizard Shazam, Mary Marvel, Captain Marvel Jr, Black Adam, Uncle Dudley, Tawky Tawny and anyone from the Shazamily.
[link]


2024.05.19 00:23 Kaenguruu-Dev How to structure code for splittable conveyors

Hey, so I'm currently trying to develop a game where it is very important that I can split a conveyor after having built it. The animation of items moving over it isn't that important at the moment. Here's a video that shows most of how it's supposed to work.
Now for the things that are not currently working:
  1. You can see that I click somewhere between two corners/endpoints of the conveyor. I want to be able to basically split that conveyor so that it now allows me to connect it to the second output. (The small rectangle on the bottom right).
My current way of storing the information looks like this:
class Conveyor: List class ConveyorSegment: ConveyorSegment Target; Vector2 Start; Vector2 End; 
That list stores Instances of ConveyorSegment (representing one straight section in a conveyor) which has a start and end position. Target points to the next ConveyorSegment that is connected.
My problem however is, that I just can't figure out how to allow the conveyor-splitting functionality because that list doesn't really have an order. If I build the conveyor and then want to add something in the middle, that new element in the list will not be in the middle of the list but at the end and I don't think there's a way to avoid that because when there are multiple splits down the line it'd just get really messy. I was thinking of making ConveyorSegment Target a list but I'm unsure how I'd then know what target to pick when I need to modify the data.
Any help is appreciated!
https://reddit.com/link/1cv8zbo/video/ccsx3y7ag91d1/player
submitted by Kaenguruu-Dev to godot [link] [comments]


2024.05.19 00:18 CheezyWookiee Me as I ask Adam Driver to say a Kylo Ren line during the live interaction segment of Megapolis

Me as I ask Adam Driver to say a Kylo Ren line during the live interaction segment of Megapolis submitted by CheezyWookiee to okbuddycinephile [link] [comments]


2024.05.18 23:59 Socalsamuel [Spoilers] Start Fresh or...?

Preorder xbox sx player, played non stop for a month or two and then burned out before the "end game", but that end game was spoiled for me so I know the jist of what awaits. With the new patch, I'm down to get back into the game. My current save has a huge missing ground segment in New Atlantis and an unfindable temple (last checked a few months ago). Wondering your thoughts: If you were in my position, would you start fresh on the new patch or load up the old save and get to the first "end game"? For reference, I have already finished the pirate faction questline, the ryugin questline, and the ranger questline. Im deep into the terrormorph questline, and deep enough into the main quest line to have one death of a major character (iykyk).
All opinions welcome.
submitted by Socalsamuel to Starfield [link] [comments]


2024.05.18 23:28 Tesa_Tesanovic1988 Exploring Performance Boosters: Synthetic Equity vs. Tokens – Which One Fits You?

In the ever-evolving landscape of modern business, companies face a critical choice when it comes to rewarding and motivating their key talent.

The debate between adopting traditional token distribution models and embracing Synthetic Equity with deferred cash payments based on performance continues to shape the compensation strategies of organizations worldwide. This expository essay aims to shed light on this important decision-making process, offering insights into the advantages and pitfalls of each approach.

Token Distribution:

Pros:
  1. Immediate Ownership: Token distribution provides immediate ownership, aligning team members with the project’s success from the outset.
  2. Strong Incentive: Tokens are potent incentives, as their value can soar if the project prospers.
  3. Transparency: Blockchain-based tokens often offer transparency and traceability in ownership and transactions.
  4. Avoiding Ownership Dilution: Tokens allow companies to avoid diluting their cap tables.
  5. Payment Efficiency: Salaries and performance-based bonuses in token form can conserve cash reserves, with employees seeking liquidity in the market.
Cons:
  1. Market Volatility: Token values can be highly volatile, creating uncertainty for team members.
  2. Limited Liquidity: Token liquidity constraints make converting tokens into cash challenging.
  3. Tax Implications: Transferring token value can trigger income tax obligations.
  4. Legal and Regulatory Compliance: Issuing tokens, especially in countries like the US, often involves legal, financial, and administrative hurdles.
  5. Access to Top Talent: High-caliber talent may be hesitant to accept tokens due to market volatility.

Synthetic Equity:

Pros:
  1. Performance-Driven: Synthetic Equity and deferred cash payments link rewards directly to individual or team performance, fostering a strong work ethic.
  2. Predictable Rewards: Cash payments offer stability and predictability compared to volatile tokens.
  3. Flexibility: Synthetic Equity and cash incentives can be customized to align with specific performance metrics and goals.
  4. Avoiding Ownership Dilution: Tokens allow companies to avoid diluting their cap tables.
  5. Value for Investors: High-performing organizations often deliver greater value to shareholders.
  6. Utility Token: Synthetic Equity tokens, being a derivative of work, carry no inherent value, making them utility tokens with fewer legal implications.
  7. Bottom-Line Impact: Additional payments are derived from bottom-line growth, directly rewarding employees for business expansion.
  8. Tax Implications: Specify payouts such as “time certain” and separation of service, all of which are 100% compensation expense for tax purposes. Have the lowest predictable cost to the company based on after- tax cash flow.
Cons:
  1. Performance management system set up: Synthetic Equity requires strong expertise in establishing performance management and incentive structures.
  2. Delayed Ownership: Synthetic Equity lacks the immediate ownership associated with tokens.
  3. Administrative Complexity: Implementing and managing a comprehensive incentives program can be administratively intricate.
SyntheticEquity.io combines innovative compensation strategies designed to simulate the value of actual equity shares.
Synthetic Equity offers an alternative to the traditional token issuance model, integrating performance management seamlessly. It aligns stakeholder and shareholder interests, encourages innovation, and rewards high performance. Furthermore, it addresses a common challenge faced by startups—creating and measuring key performance indicators (KPIs). Our unique performance plan methodology enhances teamwork, promotes a healthier work environment, and ensures individual productivity by emphasizing collective success.
Synthetic equity is ideal for companies committed to thriving and nurturing top talent. Individuals who meet their KPIs are rewarded, while those failing to contribute positively to the business unit’s performance forfeit part of their compensation.
The decision between token distribution and Synthetic Equity hinges on an organization’s objectives, risk tolerance, and the preferences of founders and team members. Some organizations may choose a combination of both to balance immediate ownership and performance-based incentives. Legal, regulatory, and tax considerations, as well as project dynamics, must be carefully weighed. Consulting with legal and financial experts can prove invaluable in crafting an effective and compliant compensation strategy.
Synthetic equity is a powerful tool for attracting, retaining, and rewarding top talent, especially in owner succession planning. However, many business owners and advisors possess only a rudimentary understanding of synthetic equity and its design. This essay defines synthetic equity, explores its appropriateness for specific capital and tax structures, illustrates its flexibility and benefits in owner succession, and showcases its potential through a compelling case study.
Synthetic equity, unlike traditional equity plans, is a compensation approach that grants executives and contract-based employees the right to a defined portion of enterprise value without requiring them to invest their own capital. It offers exceptional versatility and can be tailored to meet specific criteria related to who receives what, when, and under what conditions in terms of value sharing.
Outlined below are six fundamental examples of synthetic equity programs:
  1. Phantom Stock:
    • An executive is entitled to a percentage share of the company’s value. (For example, Joe holds 5% of the company’s value expressed as phantom stock.)
  2. Phantom Stock Over an Owner’s Threshold:
    • An executive has the right to a percentage share of the company’s value beyond an initial fixed threshold value or formula. (For instance, Joe has 5% of the company’s value above $10 million.)
  3. Stock Appreciation Rights (SARs):
    • Executives are granted the right to share in a set percentage of the company’s value exceeding its value at the time of the grant—similar to employee stock options. (For instance, Joe has 5% of the company’s value above the current valuation of $20 million.)
  4. Value Band Plans:
    • Executives are entitled to a graduated percentage share of the company’s value based on predetermined thresholds. (For example, Joe has a baseline right to 3% of the company’s value and can earn an additional 1% for every $10 million in growth, with a maximum share of 7%.)
  5. Sales Bonus in Event of Change of Control:
    • Executives are entitled to a percentage share of the company’s value payable exclusively in the event of a change of control. (For example, Joe has 5% of the company’s value expressed as phantom stock, payable only if a change of control occurs.)
  6. Simulated Equity Plan:
    • Executives are entitled to a percentage share of the value of a specific division or segment of the company, determined by a predefined formulaic breakup value of the company. (For instance, Joe holds 5% of the European division’s value based on a preset formulaic breakup value of the company.)
These diverse synthetic equity programs offer flexibility and the ability to tailor incentive structures to meet specific business objectives and circumstances.
The possibilities are virtually endless. Synthetic equity is akin to a sculptor’s clay for incentive structures—it can be molded into a wide array of forms to suit a business owner’s preferences. It can transform from a tracking stock to a pure performance-based incentive.
Of significant significance to business owners, synthetic equity operates independently of the company’s shareholders’ agreement and related buy-sell terms. This independence grants a high degree of flexibility, particularly concerning payout. Synthetic equity agreements must adhere to IRS code section 409A, which outlines rules governing plan payouts. According to 409A, synthetic equity plans can be triggered by six permissible events or plan termination. The three events that cannot be predicted are death, disability, and unforeseeable emergencies, while the three strategic triggers are change of control, time certain, and separation of service. Consequently, business owners have the authority to determine when executives can realize the value of the plan. This contrasts with a typical employee stock option plan, where executives decide when to “exercise” their stock options independently. In summary, synthetic equity plans provide business owners with enhanced control and flexibility in terms of plan design and payout.
In conclusion, synthetic equity stands as a compelling option for organizations seeking to optimize cash resources, empower succession, and reward high performance. It offers a robust and flexible framework, ensuring that top talent remains motivated and aligned with organizational goals. Embracing Synthetic Equity can truly set a company on the path to sustained high performance and success.
Authors

Paul Lalovich

submitted by Tesa_Tesanovic1988 to Open_innovation_model [link] [comments]


2024.05.18 23:21 Night123_ Help with tpu printing on fablicator mx series....

Help with tpu printing on fablicator mx series....
Okay so im not really experienced with 3d printing.... Im using my schools 3d printer and trying to 3d print myself a phone case we have a fablicator mx series.... And we keep experiencing errors.... If anyone knows the fix or how to prevent this please help.
submitted by Night123_ to 3Dprinting [link] [comments]


2024.05.18 23:08 FetchFrosh Whose Line is it Anime? - 10 Million Subscriber Edition

We're doing a throwback to an old thread that used to be a monthly staple on anime. "Whose Line is it Anime?" stems from the TV Show "Whose Line is it Anyway?" where one of the recurring segments was "Scenes from a Hat". In it, an idea would be drawn from a hat and the comedians on the show would come up with ideas of quick one liners or micro-skits based on the prompt.
So feel free to post prompts as top level comments, and see what other people can come up with. You want to come up with things that really let people be creative rather than ones that have one or two obvious jokes, but at the end of the day the points don't matter.
You can check here for the 1 million subscriber edition as well!
submitted by FetchFrosh to anime [link] [comments]


2024.05.18 22:17 TheBlaringBlue Kena: Bridge of Spirits is a Wolf in Sheep's Clothing (Analysis & Pseudo-Review)

Kena: Bridge of Spirits is such a good game despite being so… well… basic.
It’s simple — almost overly so — yet it is beloved by so many seasoned and experienced gamers.
What I got curious about after playing the game myself and reading a number of pseudo-reviews online was how exactly it achieved this.
How did a package so entry-level-looking garner such respect by 201 and 301 students?
--
The ‘Fields’ region is a great example of Kena’s dichotomy.
It’s gorgeous and inviting, with sea-foamed vistas, lush landscape and rushing waterways. There’s a even a big, lovable pet bull towering over the myriad of cute little Rot dudes scampering through the foliage. The whole place is just friendly.
Why then, does it end up being one of the game’s longest, deepest and most complex sections? Consider its many scattered puzzles, which ask you to combine platforming, archery, environmental awareness and combat proficiency. There’s even a handful of red herring platforms that you can’t properly interact with until later in your puzzle solving endeavor.
The ‘Fields’ are a microcosm of the game as a whole. A childish, Pixar-esque shell which, when uncovered, reveals a complex, involved gameplay experience underneath.
Kena: Bridge of Spirits invites you to be a kid, but treats you like an adult. This is something very few games manage — or even attempt — and it’s what makes Kena so unique, memorable and special.
--
Kena crushes its tone and aesthetic on all fronts to create something that’s desirable and attainable to a group outside of hardcore gamers.
Kena’s visuals are youthful and welcoming by using cartoonish and fairytale-esque art design. The game’s companions do the same — the Rot are your constant brigade of adorable little plush-like, Pikimin-esque comrades who hop as you walk, munch on berries, clumsily trip over each other, and squeak in pitches that can only described as ‘cute.’ You can even give them little hats to wear. They’re pets and it’s all so mired in youthful innocence that I cringe even typing it.
From a distance, Kena appears childish and immature based on its outward appearance. That is, until you peel back its outer layer.
--
The game looks like something your five-year-old might enjoying toying with on your iPad, “you-got-games-on-yo-phone?” style. But there are four elements in its building blocks that make it a game not optimized for your five-year-old on their own;
  1. Narrative
  2. Puzzles
  3. Platforming
  4. Combat
Narrative
As far as the game’s story is concerned, it may begin bright and innocent enough, but it deals not-abstractly with death and loss.
Consider that all three boys you meet in the early game — Taro, Benni and Saiya are actually dead, I-see-dead-people style. Consider also that Kena’s entire journey revolves around the loss of her own father and her desire to reconnect with him.
Additionally, it is Toshi’s selfishness and his desire to be the hero that actually ends up bringing death and destruction to his village when he jumps the gun and kills and the mountain spirit in cold blood.
Merciless affronts on nature and an up-front dealing with death and grief are not exactly for the young of age, despite their youthful packaging.
Puzzles
It would be a waste of word count to explain in detail the steps necessary to complete certain puzzles in Kena just as a set of examples to prove the point.
If you’ve played or watched gameplay, you know the puzzles are surprisingly involved, consisting often of multiple steps to complete that build on each other and require the use of all of your abilities in tandem.
One of the bigger “ah-hah” moments I recall was when I realized I could order my Rot minions to move objects while Kena stood on top of said object in order to give me a leg up to jump to a previously unreachable ledge.
Platforming
Speaking of ledges, jumping to and from them is tight and precise in Kena.
Platforming challenges are often timed (your aura-bomb weapon only activates platforms for specifically-timed bursts). Combining their scheduled nature with the need to rotate them via precise archery, mid-air grappling segments and more makes for a movement experience that is involved enough to demand the player’s full attention for every tick of the clock.
Kena and her world’s gravity also have a decided, predictable weight to them that’s not exactly forgiving, meaning the act of jumping to and fro is exact while also requiring exactness.
Combat
Fighting the enemies of Kena is similarly involved.
The cadence with which the game throws opponents your way combined with the complexities of dealing meaningful damage to said opponents creates a combat scenario which demands the player fluidly wield and swap between both melee and ranged options while carefully managing space on the battlefield.
Kamikaze-style enemies often rush Kena in carefully-spaced and well-timed waves, while enemies with shields and shells hide their weak points from visibility. Enemies like this require certain sequences to beat — be it a well-placed bomb and arrow combo, a parry, or a maneuvering to an enemy’s backside.
Boss encounters lean into these mechanics but also present new wrinkles — The Hunter fight asks the player to rethink their tactics and find a way to deal with an airborne opponent who is apt at dodging bombs and arrows, for example.
The final few bosses ask you to take everything you’ve learned throughout your journey and apply it all at once, and if you don’t… it’s defeat for Kena.
--
The above sounds like I’m describing a souls-like with platforming elements as the ‘fresh take’ in addition to the enrapturing combat.
Games that provide this much of a challenging, involved experience are typically darker in tone — be it music, environment, or what-have-you. I don’t think too many people would call Kena ‘hard,’ but these are the same people who died 10+ times to The Hunter or Corrupted Toshi.
If this game had a darker, moodier skin, would more people describe it as hard or not for the faint of heart?
In this way, Kena: Bridge of Spirits is a wolf in sheep’s clothing.
It is accessible to new players and younger gamers due to its pleasing and friendly atmosphere. But by its conclusion, it is likely to season them into better gamers. If a newbie gamer picks up Kena, they’re in for a surprise and (hopefully) delight when they find something deeper than that which they first expected.
On the other hand, Kena is a worthwhile experience for veteran gamers if they drop their toxic masculinity and play a goofy kids game with a female protagonist. This is a game that will undoubtedly earn their respect by requiring their attention, precision and commitment throughout its experience. Like the newbie gamers, gaming veterans are in for a surprise and (certainly) delight when they find something deeper than that which they first expected.
--
Kena: Bridge of Spirits is a good experience for everyone. By balancing being adorable with being difficult, it earns the respect and appreciation of everyone who plays it. Its accessibility makes it easy to recommend to anyone and the game thus earns itself a bigger audience as a result.
Its narrative and gameplay might not separate themselves in terms of newness from a saturated market, but the surprise and delight the game provides delivers an experience to its players that isn’t typical of the space.
By striking the balance between wolf and sheep, Kena elevates its quality to something beyond just the content within.
--
and yet
I can’t help but think, as I summarize this article, that if a game is for everyone, doesn’t that, on some level, mean it is also for no one?
I mean, when you look at the game’s narrative or gameplay, it’s not exactly reinventing the wheel here. In fact, Kena does just about nothing new. It spits out the same exact version of a game we’ve been playing for decades in the form of Tomb Raider or Uncharted or The Legend of Zelda or God of War.
Critically speaking, both the gameplay and narrative are pretty damn milquetoast.
You’re in a world infected by some arbitrary Darkness and since you’re Special and The Chosen One™ it’s your job to go around cleansing the world of evil using a combination of environmental platforming, lever and pressure plate puzzle-solving and lock-on-based, sword-swinging driven combat.
It wouldn’t be difficult to make the argument that Kena is bland.
But the discourse around the game just isn’t about that.
The game’s scored an 81 on Metacritic and has a 92% positive review rating on Steam at time of writing. It recouped its development costs in just one month, meaning every sale since then is hitting the bottom line.
People like this game.
Quick aside from me here on something that made me smile — when double-checking the score on Steam for the above info, I found these as the first two reviews at the very top of the queue: “yo wtf. bought this game to chill, why does it feels like im playing souls-like difficulty ass game HAHAHAH.” “Don’t be fooled by the graphics. This game can be a challenge at times, but it is worth the experience.”
So maybe being an experience for everyone really was the kicker?
Or, maybe, it was something else.
In fact, yeah, I can confidently say it was. It’s a game reviewer’s buzzword, but it’s oh-so apt here: polish.
--
The entire experience of playing Kena is smooth. There are no framerate drops, no bugs, no broken quests or puzzles, no desynced dialogue and facial animations. Not a single hiccup to speak of.
The game features exacting archery, precise platforming, telegraphed and accurate hitboxes, as well as an unimpeding camera, responsive and weighty combat and legible visual design that accurately communicates with the player.
You can move through Kena virtually unobstructed (until you come across a puzzle you can’t solve, but that’s your problem, not the game’s). Everything is built carefully and gels together in a cohesion that works so fluidly that playing Kena is simply frictionless.
The game’s developers — Ember Lab — nailed the fundamentals, paid attention to detail and play-tested perfectly. Their effort to go above and beyond saved this game from sinking into the obscurity of being completely and utterly Mid.
--
It’s frictionlessness that elevates Kena beyond itself. It makes the game greater than the sum of its parts. It makes Kena a complete, finished and polished experience.
Kena presents itself like it’s Disney Pixar’s latest goofy-ass, lame-ass, sub-par video game, but lying underneath the childish aesthetic is a challenging and engaging experience that’s not only a boon for all audiences of gamers, but a worthwhile one thanks to its extreme polish and dedication.
You should play it.
submitted by TheBlaringBlue to ItsAllAboutGames [link] [comments]


2024.05.18 22:17 TheBlaringBlue This Game is a Wolf in Sheep's Clothing (Analysis & Pseudo-Review)

Kena: Bridge of Spirits is such a good game despite being so… well… basic.
It’s simple — almost overly so — yet it is beloved by so many seasoned and experienced gamers.
What I got curious about after playing the game myself and reading a number of pseudo-reviews online was how exactly it achieved this.
How did a package so entry-level-looking garner such respect by 201 and 301 students?
--
The ‘Fields’ region is a great example of Kena’s dichotomy.
It’s gorgeous and inviting, with sea-foamed vistas, lush landscape and rushing waterways. There’s a even a big, lovable pet bull towering over the myriad of cute little Rot dudes scampering through the foliage. The whole place is just friendly.
Why then, does it end up being one of the game’s longest, deepest and most complex sections? Consider its many scattered puzzles, which ask you to combine platforming, archery, environmental awareness and combat proficiency. There’s even a handful of red herring platforms that you can’t properly interact with until later in your puzzle solving endeavor.
The ‘Fields’ are a microcosm of the game as a whole. A childish, Pixar-esque shell which, when uncovered, reveals a complex, involved gameplay experience underneath.
Kena: Bridge of Spirits invites you to be a kid, but treats you like an adult. This is something very few games manage — or even attempt — and it’s what makes Kena so unique, memorable and special.
--
Kena crushes its tone and aesthetic on all fronts to create something that’s desirable and attainable to a group outside of hardcore gamers.
Kena’s visuals are youthful and welcoming by using cartoonish and fairytale-esque art design. The game’s companions do the same — the Rot are your constant brigade of adorable little plush-like, Pikimin-esque comrades who hop as you walk, munch on berries, clumsily trip over each other, and squeak in pitches that can only described as ‘cute.’ You can even give them little hats to wear. They’re pets and it’s all so mired in youthful innocence that I cringe even typing it.
From a distance, Kena appears childish and immature based on its outward appearance. That is, until you peel back its outer layer.
--
The game looks like something your five-year-old might enjoying toying with on your iPad, “you-got-games-on-yo-phone?” style. But there are four elements in its building blocks that make it a game not optimized for your five-year-old on their own;
  1. Narrative
  2. Puzzles
  3. Platforming
  4. Combat
Narrative
As far as the game’s story is concerned, it may begin bright and innocent enough, but it deals not-abstractly with death and loss.
Consider that all three boys you meet in the early game — Taro, Benni and Saiya are actually dead, I-see-dead-people style. Consider also that Kena’s entire journey revolves around the loss of her own father and her desire to reconnect with him.
Additionally, it is Toshi’s selfishness and his desire to be the hero that actually ends up bringing death and destruction to his village when he jumps the gun and kills and the mountain spirit in cold blood.
Merciless affronts on nature and an up-front dealing with death and grief are not exactly for the young of age, despite their youthful packaging.
Puzzles
It would be a waste of word count to explain in detail the steps necessary to complete certain puzzles in Kena just as a set of examples to prove the point.
If you’ve played or watched gameplay, you know the puzzles are surprisingly involved, consisting often of multiple steps to complete that build on each other and require the use of all of your abilities in tandem.
One of the bigger “ah-hah” moments I recall was when I realized I could order my Rot minions to move objects while Kena stood on top of said object in order to give me a leg up to jump to a previously unreachable ledge.
Platforming
Speaking of ledges, jumping to and from them is tight and precise in Kena.
Platforming challenges are often timed (your aura-bomb weapon only activates platforms for specifically-timed bursts). Combining their scheduled nature with the need to rotate them via precise archery, mid-air grappling segments and more makes for a movement experience that is involved enough to demand the player’s full attention for every tick of the clock.
Kena and her world’s gravity also have a decided, predictable weight to them that’s not exactly forgiving, meaning the act of jumping to and fro is exact while also requiring exactness.
Combat
Fighting the enemies of Kena is similarly involved.
The cadence with which the game throws opponents your way combined with the complexities of dealing meaningful damage to said opponents creates a combat scenario which demands the player fluidly wield and swap between both melee and ranged options while carefully managing space on the battlefield.
Kamikaze-style enemies often rush Kena in carefully-spaced and well-timed waves, while enemies with shields and shells hide their weak points from visibility. Enemies like this require certain sequences to beat — be it a well-placed bomb and arrow combo, a parry, or a maneuvering to an enemy’s backside.
Boss encounters lean into these mechanics but also present new wrinkles — The Hunter fight asks the player to rethink their tactics and find a way to deal with an airborne opponent who is apt at dodging bombs and arrows, for example.
The final few bosses ask you to take everything you’ve learned throughout your journey and apply it all at once, and if you don’t… it’s defeat for Kena.
--
The above sounds like I’m describing a souls-like with platforming elements as the ‘fresh take’ in addition to the enrapturing combat.
Games that provide this much of a challenging, involved experience are typically darker in tone — be it music, environment, or what-have-you. I don’t think too many people would call Kena ‘hard,’ but these are the same people who died 10+ times to The Hunter or Corrupted Toshi.
If this game had a darker, moodier skin, would more people describe it as hard or not for the faint of heart?
In this way, Kena: Bridge of Spirits is a wolf in sheep’s clothing.
It is accessible to new players and younger gamers due to its pleasing and friendly atmosphere. But by its conclusion, it is likely to season them into better gamers. If a newbie gamer picks up Kena, they’re in for a surprise and (hopefully) delight when they find something deeper than that which they first expected.
On the other hand, Kena is a worthwhile experience for veteran gamers if they drop their toxic masculinity and play a goofy kids game with a female protagonist. This is a game that will undoubtedly earn their respect by requiring their attention, precision and commitment throughout its experience. Like the newbie gamers, gaming veterans are in for a surprise and (certainly) delight when they find something deeper than that which they first expected.
--
Kena: Bridge of Spirits is a good experience for everyone. By balancing being adorable with being difficult, it earns the respect and appreciation of everyone who plays it. Its accessibility makes it easy to recommend to anyone and the game thus earns itself a bigger audience as a result.
Its narrative and gameplay might not separate themselves in terms of newness from a saturated market, but the surprise and delight the game provides delivers an experience to its players that isn’t typical of the space.
By striking the balance between wolf and sheep, Kena elevates its quality to something beyond just the content within.
--
and yet
I can’t help but think, as I summarize this article, that if a game is for everyone, doesn’t that, on some level, mean it is also for no one?
I mean, when you look at the game’s narrative or gameplay, it’s not exactly reinventing the wheel here. In fact, Kena does just about nothing new. It spits out the same exact version of a game we’ve been playing for decades in the form of Tomb Raider or Uncharted or The Legend of Zelda or God of War.
Critically speaking, both the gameplay and narrative are pretty damn milquetoast.
You’re in a world infected by some arbitrary Darkness and since you’re Special and The Chosen One™ it’s your job to go around cleansing the world of evil using a combination of environmental platforming, lever and pressure plate puzzle-solving and lock-on-based, sword-swinging driven combat.
It wouldn’t be difficult to make the argument that Kena is bland.
But the discourse around the game just isn’t about that.
The game’s scored an 81 on Metacritic and has a 92% positive review rating on Steam at time of writing. It recouped its development costs in just one month, meaning every sale since then is hitting the bottom line.
People like this game.
Quick aside from me here on something that made me smile — when double-checking the score on Steam for the above info, I found these as the first two reviews at the very top of the queue: “yo wtf. bought this game to chill, why does it feels like im playing souls-like difficulty ass game HAHAHAH.” “Don’t be fooled by the graphics. This game can be a challenge at times, but it is worth the experience.”
So maybe being an experience for everyone really was the kicker?
Or, maybe, it was something else.
In fact, yeah, I can confidently say it was. It’s a game reviewer’s buzzword, but it’s oh-so apt here: polish.
--
The entire experience of playing Kena is smooth. There are no framerate drops, no bugs, no broken quests or puzzles, no desynced dialogue and facial animations. Not a single hiccup to speak of.
The game features exacting archery, precise platforming, telegraphed and accurate hitboxes, as well as an unimpeding camera, responsive and weighty combat and legible visual design that accurately communicates with the player.
You can move through Kena virtually unobstructed (until you come across a puzzle you can’t solve, but that’s your problem, not the game’s). Everything is built carefully and gels together in a cohesion that works so fluidly that playing Kena is simply frictionless.
The game’s developers — Ember Lab — nailed the fundamentals, paid attention to detail and play-tested perfectly. Their effort to go above and beyond saved this game from sinking into the obscurity of being completely and utterly Mid.
--
It’s frictionlessness that elevates Kena beyond itself. It makes the game greater than the sum of its parts. It makes Kena a complete, finished and polished experience.
Kena presents itself like it’s Disney Pixar’s latest goofy-ass, lame-ass, sub-par video game, but lying underneath the childish aesthetic is a challenging and engaging experience that’s not only a boon for all audiences of gamers, but a worthwhile one thanks to its extreme polish and dedication.
You should play it.
submitted by TheBlaringBlue to KenaBridgeOfSpirits [link] [comments]


2024.05.18 21:03 Visible-Employment43 I can't Install speech tò text localy because isn't Easy for me. I tryed standalone version and .exe crash, i tryed whisper and It use only CPU, i tryed subtitle edit with ctranslate2 and whisper buy It wasn't "streaming" task Option, help?

I did pip install faster-whisper
. I have the audio file: - Saved the audio file i want to transcribe as audio.mp3 in the same directory as my Python script.
  1. Run the Python script: - Open a text editor and copy the provided code:
     model_size = "large-v3" 
    # Run on GPU with FP16
    model = WhisperModel(model_size, device="cuda", compute_type="float16")
    # or run on GPU with INT8
    # model = WhisperModel(model_size, device="cuda", compute_type="int8_float16") # or run on CPU with INT8
    # model = WhisperModel(model_size, device="cpu", compute_type="int8") segments, info = model.transcribe("audio.mp3", beam_size=5)
    print("Detected language '%s' with probability %f" % (info.language, info.language_probability)) for segment in segments: print("[%.2fs -> %.2fs] %s" % (segment.start, segment.end, segment.text)) - Save the file with a .py extension, for example, transcribe.py.
Python (name of file)
  1. No output: - The script Not process " Sintax invalid " line 3
Line 3 contain (model_size = "large-v3")
submitted by Visible-Employment43 to OpenAI [link] [comments]


2024.05.18 20:31 Reffick [EXCEL] Get macro to put text in particular cell reference

I have 2 columns, one with a list of cell references (P), one with text (Q). I am trying to get the text to be put in the particular cell reference from a macro.
The code I'm using keeps throwing a 'Run-time error 1004, Method 'Range' of object '_Worksheet' failed
Sub OverwriteCellReferencesWithNames() Dim ws As Worksheet Dim cell As Range Dim nameCell As Range ' Set worksheet reference to Sheet1 Set ws = ThisWorkbook.Sheets("Sheet1") ' Clear the contents of the specified ranges ws.Range("B4:F8").ClearContents ws.Range("B11:F15").ClearContents ' Loop through each cell in column P For Each cell In ws.Range("P2:P" & ws.Cells(ws.Rows.Count, "P").End(xlUp).Row) ' Get the cell reference from column P Dim cellRef As String cellRef = cell.Value ' Find the corresponding name in column Q Set nameCell = ws.Cells(cell.Row, "Q") ' If a corresponding name is found in column Q, overwrite the cell reference in column P with the name If Not nameCell Is Nothing Then ws.Range(cellRef).Value = nameCell.Value End If Next cell End Sub 
The line that that keeps throwing the error is the "ws.Range(cellRef).Value = nameCell.Value"
Any help would be appreciated!
submitted by Reffick to vba [link] [comments]


2024.05.18 19:44 throwagayaccount93 How to use the words initial point and end point when talking about rays and line segments?

Can the words be used interchangeably?
On Wikipedia it seems that a ray has one initial point and a line segment has two end points.
In my native language we use the word end point for both so I was wondering how it exactly is in English.
submitted by throwagayaccount93 to learnmath [link] [comments]


2024.05.18 19:40 TbProductions1 Flexi Rexi’s

I’ve been trying to make a flexi rex with stronger links but everything i try it just ends up combining the segments and won’t work like it should. rn i’m using 15% infill density and 0.35mm line width if that helps.
submitted by TbProductions1 to Ender3Pro [link] [comments]


2024.05.18 17:51 udemezueng The Biggest Email Marketing Mistakes (and How to Avoid Them)

Hey Reddit, so this one time, I was running on fumes trying to get an email blast out before a sale. Classic rookie mistake, right? Hit send, poured a cup of much-needed coffee, and then... dread. Subject line? "50% off the WRONG product!!" ‍♂️
Let's just say my inbox wasn't a happy place after that. But hey, it happens to the best of us! That's why I wanted to share some war stories (and how to avoid them) from the trenches of email marketing:
1. The Wrong Target Audience
Imagine sending emails about cat food to dog owners. Not gonna fly. Segment your lists! Tailor your message to different interests for better engagement.
2. Subject Line Snoozefest
"Important Update" isn't exactly setting pulses racing. Craft creative, clear subject lines that spark curiosity and get people to open up.
3. Hitting the Spam Button
All caps, weird symbols, and SCREAMING FONT are one-way tickets to the spam folder. Keep it professional, and friendly, and avoid spammy language.
4. The Disappearing Act
Don't leave your subscribers hanging! Include a clear call to action (CTA) telling them what you want them to do next, whether it's visiting a website or making a purchase.
5. The Neverending Story
Nobody wants to spend their day wading through a novel in their inbox. Keep your emails concise and scannable. Bullet points, visuals, and short paragraphs are your friends.
submitted by udemezueng to Emailmarketing [link] [comments]


2024.05.18 17:24 TheLotStore Tips for Developing 20 Acres of Land: Maximizing the Potential of Your Property

Tips for Developing 20 Acres of Land: Maximizing the Potential of Your Property
Tips for Developing 20 Acres of Land: Maximizing the Potential of Your Property
Tips for Cultivating 20 Acres of Land: Maximizing the Potential of Your Property
Cultivating 20 acres of land poses a substantial challenge. Whether you are an experienced developer or a first-time landowner, the endeavor of maximizing your property's potential can seem daunting and intricate. Nevertheless, with meticulous planning, thorough research, and strategic implementation, it is feasible to transform your 20-acre property into a lucrative and flourishing enterprise.
In this write-up, we will present recommendations and tactics for cultivating 20 acres of land, encompassing land usage planning, zoning statutes, site design, infrastructure growth, and environmental considerations. Furthermore, we will encompass various development ventures, such as residential, agricultural, commercial, and recreational, while imparting counsel on choosing the appropriate approach for your property.
Comprehension of Your Property
Before embarking on a development initiative, it is imperative to comprehend the distinctive attributes and potential of your 20 acres of land. Conducting a comprehensive land evaluation will aid in recognizing the natural characteristics, topography, soil conditions, and environmental influences that can sway the type of cultivation you pursue.
Commence by acquiring a survey of the property to delineate boundary lines, easements, and standing edifices. Acquaint yourself with local zoning regulations and land usage designations to grasp the authorized applications and development benchmarks for your property. Moreover, consider executing a feasibility assessment to gauge market demand, competition, and the economic viability of potential development initiatives.
Developing a Land Usage Scheme
A well-defined land usage scheme is crucial for maximizing your property's potential. This schema should delineate the long-range vision for the development, covering land usage types, building density, infrastructure prerequisites, and environmental considerations.
Reflect on collaborating with a land planner or an architect to devise a site design that optimizes the land's natural attributes while adhering to regulatory requirements. The land usage scheme should also address aspects such as access and circulation, utilities and infrastructure, open space and landscaping, and stormwater management.
When drafting the land usage scheme, it is imperative to heed the specific aspirations and objectives for the property. Are you aiming to cultivate a residential community, a commercial hub, an agricultural enterprise, or a recreational facility? Each development category will entail unique prerequisites and considerations, hence customizing the land usage scheme to align with your vision is paramount.
Navigating Zoning Statutes
Zoning statutes play a pivotal role in shaping the development potential of your property. These statutes dictate the permissible land usages, building categories, setback requisites, lot coverage, and additional development standards that must be complied with when devising a project.
Prior to finalizing your land usage scheme, consulting with the local planning department to fathom the zoning prerequisites and constraints applicable to your property is indispensable. Contemplate enlisting the expertise of a land usage attorney or a zoning advisor to navigate the regulatory process and ensure conformity with local zoning decrees.
In certain instances, seeking a rezoning or a variance may be necessary to accommodate your development objectives. This process commonly entails submitting an application to the planning commission or zoning board and articulating your rationale for the desired adjustments. Be prepared to furnish a persuasive argument, bolstered by professional planning and design proficiency, to substantiate the requested amendments to the zoning statutes.
Infrastructure Growth
Developing 20 acres of land frequently entails constructing infrastructure to support the proposed land usages. This may encompass roadways and parking zones, utilities such as water, sewerage, and electricity, and other indispensable amenities to facilitate development.
When strategizing for infrastructure growth, it is imperative to contemplate the long-term requisites of the property. Engaging with civil engineers and utility providers to contrive and execute a comprehensive infrastructure system capable of buttressing the intended development while curbing environmental impacts and conserving the land's natural attributes is pivotal.
Budgeting for infrastructure growth is another critical consideration. Depending on the scope of the project, infrastructure expenditures can rapidly accumulate and profoundly influence the overall viability of the development. Hence, undertaking an exhaustive cost analysis and securing the essential financing to underwrite the infrastructure construction is essential.
Environmental Considerations
Developing 20 acres of land mandates meticulous attention to environmental factors to ensure sustainable and responsible development. Conducting a thorough environmental assessment to identify any potential ramifications on wetlands, wildlife habitats, water resources, and other natural attributes of the property is imperative.
Collaborate with environmental consultants and regulatory agencies to devise a mitigation plan addressing potential environmental repercussions and ensuring adherence to local, state, and federal regulations. This may encompass implementing strategies to mitigate soil erosion, safeguard water quality, conserve natural resources, and preserve delicate ecological regions.
Incorporating sustainable design practices into the development can also enhance the environmental quality of the property. Ponder integrating green infrastructure, energy-efficient edifices, and landscaping fostering biodiversity and curbing water consumption. By assimilating sustainable design principles, you can shape a development that is not only environmentally conscientious but also appealing to prospective buyers or lessees.
Types of Development Ventures
An array of development ventures can be pursued on 20 acres of land, each furnishing unique prospects and challenges. Depending on your objectives and the property's attributes, you may explore residential, agricultural, commercial, or recreational development.
Residential Development
Residential development on 20 acres of land can manifest in various forms, such as detached homes, townhouses, or condominiums. Deliberate the demand for residential properties in the vicinity, the availability of infrastructure, and the natural amenities capable of attracting potential homebuyers.
Prior to embarking on a residential development enterprise, conducting a comprehensive market analysis to grasp housing demand, price trends, and demographic characteristics of the target market is vital. Ponder engaging a real estate consultant or a market researcher to pinpoint the most suitable housing types and market segments for the development.
Agricultural Expansion
Agricultural expansion on 20 acres of land presents prospects for farming, ranching, or agri-tourism. Reflect on the soil quality, climate, and water availability to ascertain the most fitting agricultural pursuits for the property.
Seek insights from agricultural specialists and extension agents to grasp the local farming conditions and market prospects for agricultural products. Explore the potential for specialty crops, organic farming, livestock husbandry, or other value-added agricultural pursuits capable of generating income and contributing to the local food economy.
Commercial Development
Commercial development on 20 acres of...plot can encompass retail, office, industrial, or mixed-use projects. Take into account the prominence, entry, and market request for commercial space to decide the most feasible commercial uses for the property.
When orchestrating a commercial development, thorough feasibility assessment is crucial to evaluate the market request, competitive environment, and financial potential for the suggested commercial uses. Consider the local demographic and economic patterns, and also the suitability of the suggested commercial actions with the adjacent land uses.
Recreational Expansion
Recreational expansion on 20 acres of land can involve facilities such as parks, paths, athletic venues, or nature reserves. Consider the inherent traits of the property, such as water bodies, woodlands, or panoramic views, and decide on the most suitable recreational uses to enhance the location.
When planning a recreational expansion, it is essential to consider the recreational necessities of the local community and the potential to draw visitors from outside the area. Collaborate with recreation planners and landscape designers to create a recreational facility that offers varied and reachable recreational opportunities for individuals of all ages and abilities.
Selecting the Correct Strategy
Ultimately, the accomplishment of developing 20 acres of land depends on selecting the appropriate strategy that aligns with your objectives, assets, and market possibilities. Take into consideration the following elements when evaluating the most appropriate expansion strategy for your property:
Market Request: Evaluate the present and future request for the suggested land uses, taking into account demographic patterns, financial conditions, and competitive elements.
Financial Feasibility: Conduct an extensive monetary analysis to evaluate the expenses, profits, and prospective returns on investment for the suggested expansion.
Resource Accessibility: Consider the availability of funding, infrastructure, and labor force needed to back up the suggested development.
Statutory Restrictions: Assess the statutory prerequisites, zoning restrictions, and ecological aspects that may impact the viability of the expansion.
Property Traits: Bear in mind the natural features, topography, soil conditions, and other site-specific elements that may influence the expansion potential of the property.
By fully considering these elements, you can make a well-informed decision on the most appropriate strategy for expanding your 20 acres of land.
Conclusion
Expanding 20 acres of land offers a distinctive prospect to craft a vibrant and sustainable expansion that maximizes the potential of the property. By comprehending the property traits, navigating zoning regulations, planning for infrastructure expansion, and taking ecological factors into account, you can formulate an expansion that enhances the community and yields a favorable return on investment.
Whether you are pursuing residential, agricultural, commercial, or recreational expansion, it is essential to carry out thorough research, team up with professional specialists, and formulate a comprehensive land use blueprint that aligns with your goals and assets. By adhering to the guidance and strategies outlined in this article, you can embark on a successful expansion endeavor that transforms your 20 acres of land into a flourishing and valuable asset.
View our amazing property deals at TheLotStore.Com.
Additional Information: https://thelotstore.com/tips-for-developing-20-acres-of-land-maximizing-the-potential-of-your-property/?feed_id=10815
submitted by TheLotStore to u/TheLotStore [link] [comments]


2024.05.18 16:38 No-One7863 Grab Holdings

(NASDAQ:GRAB), a ride-hailing platform, has shown impressive revenue growth and is popular among hedge funds.
GRAB has long been one of my favorite penny stocks due to its strong presence in Southeast Asia and its expanding top and bottom lines. The developing economies of Vietnam and Thailand will be a boon for GRAB.
GRAB had a solid previous financial year, demonstrating a 65% year-over-year (YoY) revenue increase to $2.36 billion, surpassing its guidance. This growth was attributed to across all segments, incentive optimization, and a business model change in its delivery offerings.
The company also marked a 72% YoY improvement in its annual loss to $485 million, mainly due to better Group Adjusted EBITDA and lower fair value losses on investments.
Analysts have a positive outlook on GRAB, rating the stock as a “Strong Buy” with a price target of $5.08, indicating a potential upside of 59.25% from its current price.
submitted by No-One7863 to PENNYSTOCKFINDER [link] [comments]


2024.05.18 16:08 portersdad Preferred Stock And Customer Appreciation

Preferred Stock And Customer Appreciation
There’s been some informative initial breakdowns here of the GameStop’s recent S-3ASR… what possibilities it opens up to the company. But I think I’ve connected what Larry Cheng may be hinting at with his “Customer Appreciation Cost” tweets and how it relates to this filing and his “productive week.”
First, going to take a quick look at his “due diligence” tweet (https://x.com/larryvc/status/1790693166498066804?s=46) though to set the stage. People have noted he both starts and ends the tweet very similarity - it’s right in front of us all along.
He BOOKENDED the tweet with, “word-by-word, line-by-line, number-by-number”
One could even be tempted to continue that phrase … “number-by-number, and book-by-book.”
Now - his next tweet starts “Random thought on Customer Acquisition Cost (CAC) Payback”. https://x.com/larryvc/status/1790846573334626681?s=46
In this tweet he’s basically saying CAC shouldn’t necessarily be reflected in financial analysis the way most people look at it. Side note: He also mentions a subscription model here.
In his next tweet he continues on this topic (https://x.com/larryvc/status/1791157552757055529?s=46).
“It's equally as important to understand the lifetime value (LTV) by customer-type because that drives the ceiling on CAC for that customer-type.
As an example:
Customer Type A LTV = $1,000 Customer Type A CAC = $100 Customer Type A LTV:CAC = 10x
Customer Type B LTV = $160 Customer Type B CAC = $80 Customer Type B LTV:CAC = 2x
You would much rather pay a higher CAC to acquire Customer Type A given the superior LTV:CAC dynamics.
When you look at CAC only by acquisition channel, it's easy to default to scaling the lowest cost channel without completely understanding the quality and economics of the customer being acquired through that channel. It may be that a more expensive channel is more economic if it's acquiring a higher quality, higher retaining customer.
Therefore the optimal analysis overlays customer segment LTV/CAC with acquisition channel economics/CAC to find the optimal seam in the business.”
Well - who are GME’s preferred customers?
Probably the most loyal ones who BUY, HODL, DRS, right?!?
Those who have booked their shares - provide more long term VALUE (some might say deep fucking value) to the company.
The filing allows them to provide a dividend in book entry. And could therefore be used to give a larger dividend to those in book entry, or preferred stock for proffered customers, or perhaps if not cash or stock, something more meaningful. I’ll let you all debate what that could be. Personally, I think Wu Tang Clan is for the children. And there’s nothing more memetic/poetic than destroying Wall Street with an album they stole from the people.
Power to the players.
“It’s been a productive week…” - Larry Cheng, May 17 at 5:11pm
As I was putting this together, Larry tweeted again, further cementing they have a plan IMO: “Three sub-plans essential to any overarching corporate financial goal:
-A P&L plan -A balance sheet plan -A cash flow plan
It's common to over-index to one. But, to hit on all cylinders, there should be execution plans across all three for any single corporate financial goal.” https://x.com/larryvc/status/1791814692530168302?s=46
TA;DR - LC hinted at reviewing DD on the OG thesis - book-by-book. His tweet was “BOOKended”. His next tweets are “random” about customer appreciation. I believe he is outlining that different stock holders may receive different dividends based on how their shares are “booked”. Preferred stock or larger dividend for long term value (deep fucking value) customers - those who have DRSed. LC makes the business case for why a company would do this.
submitted by portersdad to Superstonk [link] [comments]


2024.05.18 16:06 Downtown-Database192 Market Updates

As per a market veteran, greed is at every level. There is greed with F&O traders, hedge funds and exchanges facing M/W/D expiry. Since greed at such expiries are natural, why blame hedge funds for our actions and losses? It is wrong to blame others for our failure to understand the risks of F&O trading. If retail investors don't know the tricks of trading, they should simply step aside and do nothing. Volatility on expiry day is a given fact. One should know how to play against the big sharks or else stay away from F&O trading. We just create excuses for our failure in understanding the terms of business and the risks involved as everyone is addicted to F&O trading despite the huge losses. It is impossible for them to control their greed. Interpreting the right direction on expiry day is a must if one has to survive the volatility in the markets.
As per a market veteran, when market is on its peak, avoid tip and rumor-based trading, as there are chances of getting trapped. Do your own research for every company you choose to invest in. Follow very strictly the single rule allocation - not more than 7-9% of the portfolio in a single stock even if the promoter says so. Do not trade if the concept of the trade is not clear in your mind. Till 4th June, there will be wild volatile swings both ways. But if you have taken a trade without having the clear concept, you will get trapped.
As per a market veteran, never sell your winners to average out your losers! Otherwise, the day is not far when you will end up having a bunch of losers only! Bull markets are like marathons. Those who run it know the importance of consistency and discipline. People expect calamities and catastrophic in steady bull markets. So invest energy to develop patience and face them. Ride the tide and don’t time the ride.
Eco Recycling, first identified by Money Times two-years back and billed as a potential multi-bagger in our Panchratna newsletter this February has posted excellent results and the stock is on its upward journey.
In our 6th Jan MTTs, Sika Interplant recommended at Rs.1395 touched Rs.2504.
In our 21st Oct MTTs, Techno Ele. recommended at Rs. 514 touched Rs.1135.
In our 11th May MTTs, RAMINFO recommended at Rs.143 touched Rs.159, DCM Shriram Ind. recommended at Rs.195 touched Rs.220, Shemaroo recommended at Rs.157 touched Rs.165, Gulshan Polyoils recommended at Rs.197 touched Rs.205.
IRB Infra Q4 PAT grew 45% to Rs.189 cr. and consolidated income rose 47% to Rs.2504 cr. It has a equity of Rs.604 cr. and reserve of Rs.13141 cr. Total aggregate payout of Rs.181 cr. towards final dividend and third interim for FY24 has been declared. Add for decent gains.
Last week, Axis MF bought 26 lakh shares of Anantraj. Keep on radar for decent gains in medium-long term.
Va Tech Wabag results will be declared on 21st May 2024, which are expected to be encouraging. Keep it on your radar.
PNC Infratech results will be declared on 24th May 2024, which are expected to be strong. Further, a health dividend is also expected. Keep it on your radar.
ITD Cementation results will be declared on 28th May 2024, which are likely to be encouraging. Further, a health dividend is also expected. Keep it on your radar.
Vibrant Global notched an EPS of Rs.17.5 in the last 6 months and trades at a P/E of 4x. Promoters hold 71.3% and renowned fund manager, Siddharth Bhaiya, holds 22.64%. Its results on 18th May 2024 are likely to be promising with a healthy dividend. Add for multi bagger gains.
Shri Bajrang Alliance caters to Jubliant Foods, Nestle, KFC & Lulu Group for exports and exports to Australia, USA, Netherlands, Middle East, UK and New Zealand. It posted 9M EPS of Rs.29.77 and trades at a P/E of 8.5x. Buy for multi-bagger gains.
Debt-free Elixir Capital posted Q4 EPS of Rs.13.55 and FY24 EPS of Rs 26.89. It trades at a P/E of 4x. Promoters hold 71.3%, HNI’s & corporates hold 15.93%. Keep it on your radar.
Himatsingka Seide results on 23rd May 2024, which are expected to be strong with a healthy dividend. Keep it on your radar.
Kabra Extrusion Q4 NP rose 450% to Rs.18.97 cr. and declared a dividend of 70%. It is the industry leader 40% market share and partners Hero MotoCorp to supply battery packs & chargers. Thus, FY25 is expected to be the best. Add for 30% gains.
PNB Q4 NP rose 159.8% to Rs.3,010 cr. from Rs.1,159 cr. YoY and 35.4% to Rs.3,010 cr. from Rs.2,223 cr. QoQ. Its FY24 NP grew 228.8% to Rs.8,245 cr. and declared a divided of 75%. Add for decent gains.
Godrej Agrovet is into animal feed, crop protection, dairy, oil palm, poultry & processed foods. Promoters hold 74%, DIIs & FIIs hold 16.3%. It posted FY24 NP of Rs.359 cr. and declared a dividend of 100%. Add for 30% gains.
HCC results on 24th May 2024 are expected to be excellent. Keep it on your radar.
Andhra Petrochemicals Q3 NP grew 923% to Rs.9.82 cr. from Rs.0.96 cr. YoY. Its tie-up with GAIL for Natural Gas will lower production cost and boost its bottom-line. It results on 25th May 2024 are expected to be strong and a healthy dividend is likely. Buy for hefty gains.
Artefact Projects has huge orders for 6 years having bagged Rs.5.50 cr. order from NHAI. It pre-paid its debt of Rs.5 cr. and trades at a P/E of 8x and P/B of 0.86x. Its Q3 NP grew 60% and 9M NP rose 53%. It results on 21st May 2024 are expected to be good. Keep it on your radar.
TVS Holdings not only holds TVS Motor shares but is also engaged in the booming real estate business. Recently, it took over an NBFC aslo. Accumulate.
Hero MotoCorp is going ultra-aggressive in the two-wheeler segment and in the stock market too. Catch it before it goes out of reach. Add.
Maruti Suzuki remains unmatched in its market share, new models, distribution reach & service excellence. The stock is likely to speed up. Accumulate.
Fineotex Chemical receives an in-principle approval from BSE & NSE for preferential issue of warrants. It is in advanced talks for acquisition of a specialty chemicals unit. Add.
JTL Industries posted its highest-ever sales volume of 3,41,846 TPA for FY24 and posted revenue of Rs.2040.2 cr. on the back of robust demand. Buy.
Cellecor Gadgets record significant growth as it broadens its reach, distribution channels & product offerings, which boosted its marketing success. Add.
One Point One Solutions FY24 revenue grew 21.44% YoY to Rs.175.16 cr., EBITDA grew 52.95% YoY to Rs.56.76 cr. and PAT grew 143.5%. Add.
Sakuma Exports announced a substantial investment of £7.1 million in its wholly-owned subsidiary, Sakuma Impex Ltd. UK., which has an order book of £5 million. Add.
Sawaca Business Machines receives strategic proposal from TCS IT Dubai to develop AI based SCM, which includes acquisition of 20-25% stake in Sawaca Business Machines. A big positive. Buy.
Gujarat Toolroom's Rs.572.5 cr. Hybrid-Green Energy Power plant is projected to generate yearly profit of Rs.145.82 cr. Add.
Univastu India into civil construction projects has a Mkt.Cap. of Rs.237 cr. and posted Q3 sale of Rs.29.93 cr. with PAT of Rs.2.49 cr. and Q4 is likely to be better. Strong growth likely amid the infra boom. Buy.
Aartech Solonics, a turnaround player in Electrical Machinery boasts record order book and expansion plans. With investments in USA & UK subsidiaries, is poised for multi-bagger returns in the fancied Defense & Power sectors. Its Q4 results on 30th May 2024 may spring a pleasant surprise to shareholders. Buy.
Rudra Global Infra Products, manufactures TMT Bars, serving top clients like L&T and Reliance. Recently doubled production capacity and launched Rudra Inframart stores. Strong growth expected amid govt.'s infra investments. Buy.
NSE SME-listed ROX Hi-Tech evolved from an IBM & Cisco Business Partner to offer comprehensive IT solutions including AI. It is expected to notch an EPS of Rs 10 in FY24. Its IPO capex of Rs 50 cr. may lead to FY25 EPS of Rs 15+. Buy for hefty gain.
Zero-debt Just Dial from Reliance fame provides local search services through various platforms such as the internet, mobile internet, over the telephone (voice) & text (SMS). It posted 37% higher Q4 EPS of Rs.13.6 and 126% higher FY24 EPS of Rs. 42.7. Buy for 25% gain.
Union Bank has clocked 54% higher FY24 EPS of Rs.19.2. Buy for 20% gain.
Sandesh, Gujarati newspaper, published from 7 centers, posted 74% higher Q3 EPS of Rs.76.2 and 28% higher 9M EPS of Rs.154.3 on small equity of Rs.7 cr., which may lead to FY24 EPS to Rs.185/190. Buy for 25% gain.
Bank of India posted 35% higher Q4 EPS of Rs.4.6 and 65% higher FY24 EPS of Rs.15.5. Buy.
Repco Home Finance posted 36% higher Q3 EPS of Rs.18.2 and 32% higher FY24 EPS of Rs.66.6, which may lead to FY25 EPS of Rs.82+ Buy for a decent gain.
Jammu & Kashmir Bank posted Q4 EPS of Rs.5.8 and FY24 EPS of Rs.6.8. The robust Q4 EPS indicates that FY25 EPS may lead to Rs.24. Buy for 25% gain.
Nile Ltd., manufacturer of Pure Lead & Lead Alloys, plans a Lithium-ion recycling plant. It posted 140% higher Q3 EPS of Rs.39.7 and 78% higher 9M EPS of Rs.84.2, which may lead to FY24 EPS to Rs.125+. Add.
Karur Vysys Bank posted 36% higher Q4 EPS of Rs.5.7 and 45% higher FY24 EPS of Rs.20. Investments in Govt securities rose 19% to Rs.22,344 cr. in FY24, which may lead to FY25 EPS of Rs.27/28. Buy for 20% gain.
NCL Industries posted 152% higher Q4 EPS of Rs.5.2 and 110% higher FY24 EPS of Rs.20.5. Buy for 25% gain.
GPIL into iron ore mining, iron ore pellets, sponge iron, steel billets, rounds & wires, silico manganese, ferroalloys, prefab galvanized with captive power plants is expected to clock an EPS of Rs. 65. Buy for the long term.
Jaysynth Dyestuff manufacturer & dealer in dyes, dyes intermediates, organic chemicals, textile auxiliaries, pigments, resins, plasticizers & emulsions with low equity capital of Rs.0.9 cr. and is all set to garner an EPS of Rs. 9.5/10. Buy for the long term.
Basilic Fly Studios has a strong order book ~ Rs. 80 cr. to be executed in H1FY25, of which 75% is of FY24 total revenue.
Praveg launched Praveg Beach Resort at Nagoa Beach, Diu on May 15, featuring 31 Premium Tents and 4 dual-bedroom suites. It projects a 40-50% occupancy rate and an Average Room Rate of Rs.7,000-9,000. It is also expanding to 12 properties & developing 14 new projects.
Supreme Power Equipment secures Rs. 11.32 crore order to supply 50 MVA transformers for a solar project by Sept 2024, raising its total order book to Rs. 49.52 crore.
Praveg secures a 30-year land lease in Jawai, Rajasthan, for a luxury cave resort with 12 cave rooms, 8 tents, a pool, restaurant, bar & safari experiences, offering a blend of luxury & cultural immersion.
Wardwizard Innovations & Mobility post 135% YoY growth in EV sales of 1,071 units compared to 455 units in April 2023 with retail sales reaching 1,212 units in April 2024.
Mitsu Chem Plast currently operating at 70% of its 26,206 TPA capacity to expand by 1,800 TPA by May 2024 investing Rs. 206.5 lakh in new machinery.
BEL has a healthy order book. All it manufactures is a part of the Aatmanirbhar Bharat's programme and is expected to post a strong FY24 along with a good dividend/ bonus. Add.
Shyam Metaliks plans to establish a SS bright bars capacity of 25,000 TPA and an SS wires division with a capacity of 18,000 TPA. Add.
M&M Q4 NP rose 32% YoY to Rs.2,038 cr. and revenue grew 11% YoY. Further, it approved an investment of Rs.12,000 cr. for its EV Subsidiary. Add.
Eicher Motors’s unit, VE Commercial Vehicles signs a JV with I Triangle Info tech. A big positive. Further, it plans to launch its first electric Royal Enfield bike by 2025. Buy.
Glaxo (GSK) Q4 NP rose 46% to Rs.194.5 cr. It now plans 12 launches from 2025, which include new vaccines & medicines for HIV, oncology, respiratory diseases, etc. Add.
Dixon Technologies sees a $10 bn. IT hardware opportunity in India. Recently, it signed a MOU with Acerpure for manufacturing of consumer appliance products. A big positive. Buy.
TVS Motors plans to launch a series of products in the range of 5-25 KW by 2025. Further, it also started its operation in Italy. Add.
Infosys enters in to a multi-year pact with UAE's First Abu Dhabi Bank to optimize and modernize its IT infra. A big positive. Add.
Cochin Shipyard bags huge Rs.500-1000 cr. orders from an European client for Hybrid SOVs. Further, it also has orders worth Rs.11.54 cr. from UDUPI Cochin Shipyard Ltd. Buy.
HAL Q4 profit jumped 52% to Rs.4309 cr. YoY and revenue grew 18% YoY. Analysts are still bullish on this counter. Add for the long term.
submitted by Downtown-Database192 to IndianStockResearch [link] [comments]


2024.05.18 16:06 Downtown-Database192 Market Updates

As per a market veteran, greed is at every level. There is greed with F&O traders, hedge funds and exchanges facing M/W/D expiry. Since greed at such expiries are natural, why blame hedge funds for our actions and losses? It is wrong to blame others for our failure to understand the risks of F&O trading. If retail investors don't know the tricks of trading, they should simply step aside and do nothing. Volatility on expiry day is a given fact. One should know how to play against the big sharks or else stay away from F&O trading. We just create excuses for our failure in understanding the terms of business and the risks involved as everyone is addicted to F&O trading despite the huge losses. It is impossible for them to control their greed. Interpreting the right direction on expiry day is a must if one has to survive the volatility in the markets.
As per a market veteran, when market is on its peak, avoid tip and rumor-based trading, as there are chances of getting trapped. Do your own research for every company you choose to invest in. Follow very strictly the single rule allocation - not more than 7-9% of the portfolio in a single stock even if the promoter says so. Do not trade if the concept of the trade is not clear in your mind. Till 4th June, there will be wild volatile swings both ways. But if you have taken a trade without having the clear concept, you will get trapped.
As per a market veteran, never sell your winners to average out your losers! Otherwise, the day is not far when you will end up having a bunch of losers only! Bull markets are like marathons. Those who run it know the importance of consistency and discipline. People expect calamities and catastrophic in steady bull markets. So invest energy to develop patience and face them. Ride the tide and don’t time the ride.
Eco Recycling, first identified by Money Times two-years back and billed as a potential multi-bagger in our Panchratna newsletter this February has posted excellent results and the stock is on its upward journey.
In our 6th Jan MTTs, Sika Interplant recommended at Rs.1395 touched Rs.2504.
In our 21st Oct MTTs, Techno Ele. recommended at Rs. 514 touched Rs.1135.
In our 11th May MTTs, RAMINFO recommended at Rs.143 touched Rs.159, DCM Shriram Ind. recommended at Rs.195 touched Rs.220, Shemaroo recommended at Rs.157 touched Rs.165, Gulshan Polyoils recommended at Rs.197 touched Rs.205.
IRB Infra Q4 PAT grew 45% to Rs.189 cr. and consolidated income rose 47% to Rs.2504 cr. It has a equity of Rs.604 cr. and reserve of Rs.13141 cr. Total aggregate payout of Rs.181 cr. towards final dividend and third interim for FY24 has been declared. Add for decent gains.
Last week, Axis MF bought 26 lakh shares of Anantraj. Keep on radar for decent gains in medium-long term.
Va Tech Wabag results will be declared on 21st May 2024, which are expected to be encouraging. Keep it on your radar.
PNC Infratech results will be declared on 24th May 2024, which are expected to be strong. Further, a health dividend is also expected. Keep it on your radar.
ITD Cementation results will be declared on 28th May 2024, which are likely to be encouraging. Further, a health dividend is also expected. Keep it on your radar.
Vibrant Global notched an EPS of Rs.17.5 in the last 6 months and trades at a P/E of 4x. Promoters hold 71.3% and renowned fund manager, Siddharth Bhaiya, holds 22.64%. Its results on 18th May 2024 are likely to be promising with a healthy dividend. Add for multi bagger gains.
Shri Bajrang Alliance caters to Jubliant Foods, Nestle, KFC & Lulu Group for exports and exports to Australia, USA, Netherlands, Middle East, UK and New Zealand. It posted 9M EPS of Rs.29.77 and trades at a P/E of 8.5x. Buy for multi-bagger gains.
Debt-free Elixir Capital posted Q4 EPS of Rs.13.55 and FY24 EPS of Rs 26.89. It trades at a P/E of 4x. Promoters hold 71.3%, HNI’s & corporates hold 15.93%. Keep it on your radar.
Himatsingka Seide results on 23rd May 2024, which are expected to be strong with a healthy dividend. Keep it on your radar.
Kabra Extrusion Q4 NP rose 450% to Rs.18.97 cr. and declared a dividend of 70%. It is the industry leader 40% market share and partners Hero MotoCorp to supply battery packs & chargers. Thus, FY25 is expected to be the best. Add for 30% gains.
PNB Q4 NP rose 159.8% to Rs.3,010 cr. from Rs.1,159 cr. YoY and 35.4% to Rs.3,010 cr. from Rs.2,223 cr. QoQ. Its FY24 NP grew 228.8% to Rs.8,245 cr. and declared a divided of 75%. Add for decent gains.
Godrej Agrovet is into animal feed, crop protection, dairy, oil palm, poultry & processed foods. Promoters hold 74%, DIIs & FIIs hold 16.3%. It posted FY24 NP of Rs.359 cr. and declared a dividend of 100%. Add for 30% gains.
HCC results on 24th May 2024 are expected to be excellent. Keep it on your radar.
Andhra Petrochemicals Q3 NP grew 923% to Rs.9.82 cr. from Rs.0.96 cr. YoY. Its tie-up with GAIL for Natural Gas will lower production cost and boost its bottom-line. It results on 25th May 2024 are expected to be strong and a healthy dividend is likely. Buy for hefty gains.
Artefact Projects has huge orders for 6 years having bagged Rs.5.50 cr. order from NHAI. It pre-paid its debt of Rs.5 cr. and trades at a P/E of 8x and P/B of 0.86x. Its Q3 NP grew 60% and 9M NP rose 53%. It results on 21st May 2024 are expected to be good. Keep it on your radar.
TVS Holdings not only holds TVS Motor shares but is also engaged in the booming real estate business. Recently, it took over an NBFC aslo. Accumulate.
Hero MotoCorp is going ultra-aggressive in the two-wheeler segment and in the stock market too. Catch it before it goes out of reach. Add.
Maruti Suzuki remains unmatched in its market share, new models, distribution reach & service excellence. The stock is likely to speed up. Accumulate.
Fineotex Chemical receives an in-principle approval from BSE & NSE for preferential issue of warrants. It is in advanced talks for acquisition of a specialty chemicals unit. Add.
JTL Industries posted its highest-ever sales volume of 3,41,846 TPA for FY24 and posted revenue of Rs.2040.2 cr. on the back of robust demand. Buy.
Cellecor Gadgets record significant growth as it broadens its reach, distribution channels & product offerings, which boosted its marketing success. Add.
One Point One Solutions FY24 revenue grew 21.44% YoY to Rs.175.16 cr., EBITDA grew 52.95% YoY to Rs.56.76 cr. and PAT grew 143.5%. Add.
Sakuma Exports announced a substantial investment of £7.1 million in its wholly-owned subsidiary, Sakuma Impex Ltd. UK., which has an order book of £5 million. Add.
Sawaca Business Machines receives strategic proposal from TCS IT Dubai to develop AI based SCM, which includes acquisition of 20-25% stake in Sawaca Business Machines. A big positive. Buy.
Gujarat Toolroom's Rs.572.5 cr. Hybrid-Green Energy Power plant is projected to generate yearly profit of Rs.145.82 cr. Add.
Univastu India into civil construction projects has a Mkt.Cap. of Rs.237 cr. and posted Q3 sale of Rs.29.93 cr. with PAT of Rs.2.49 cr. and Q4 is likely to be better. Strong growth likely amid the infra boom. Buy.
Aartech Solonics, a turnaround player in Electrical Machinery boasts record order book and expansion plans. With investments in USA & UK subsidiaries, is poised for multi-bagger returns in the fancied Defense & Power sectors. Its Q4 results on 30th May 2024 may spring a pleasant surprise to shareholders. Buy.
Rudra Global Infra Products, manufactures TMT Bars, serving top clients like L&T and Reliance. Recently doubled production capacity and launched Rudra Inframart stores. Strong growth expected amid govt.'s infra investments. Buy.
NSE SME-listed ROX Hi-Tech evolved from an IBM & Cisco Business Partner to offer comprehensive IT solutions including AI. It is expected to notch an EPS of Rs 10 in FY24. Its IPO capex of Rs 50 cr. may lead to FY25 EPS of Rs 15+. Buy for hefty gain.
Zero-debt Just Dial from Reliance fame provides local search services through various platforms such as the internet, mobile internet, over the telephone (voice) & text (SMS). It posted 37% higher Q4 EPS of Rs.13.6 and 126% higher FY24 EPS of Rs. 42.7. Buy for 25% gain.
Union Bank has clocked 54% higher FY24 EPS of Rs.19.2. Buy for 20% gain.
Sandesh, Gujarati newspaper, published from 7 centers, posted 74% higher Q3 EPS of Rs.76.2 and 28% higher 9M EPS of Rs.154.3 on small equity of Rs.7 cr., which may lead to FY24 EPS to Rs.185/190. Buy for 25% gain.
Bank of India posted 35% higher Q4 EPS of Rs.4.6 and 65% higher FY24 EPS of Rs.15.5. Buy.
Repco Home Finance posted 36% higher Q3 EPS of Rs.18.2 and 32% higher FY24 EPS of Rs.66.6, which may lead to FY25 EPS of Rs.82+ Buy for a decent gain.
Jammu & Kashmir Bank posted Q4 EPS of Rs.5.8 and FY24 EPS of Rs.6.8. The robust Q4 EPS indicates that FY25 EPS may lead to Rs.24. Buy for 25% gain.
Nile Ltd., manufacturer of Pure Lead & Lead Alloys, plans a Lithium-ion recycling plant. It posted 140% higher Q3 EPS of Rs.39.7 and 78% higher 9M EPS of Rs.84.2, which may lead to FY24 EPS to Rs.125+. Add.
Karur Vysys Bank posted 36% higher Q4 EPS of Rs.5.7 and 45% higher FY24 EPS of Rs.20. Investments in Govt securities rose 19% to Rs.22,344 cr. in FY24, which may lead to FY25 EPS of Rs.27/28. Buy for 20% gain.
NCL Industries posted 152% higher Q4 EPS of Rs.5.2 and 110% higher FY24 EPS of Rs.20.5. Buy for 25% gain.
GPIL into iron ore mining, iron ore pellets, sponge iron, steel billets, rounds & wires, silico manganese, ferroalloys, prefab galvanized with captive power plants is expected to clock an EPS of Rs. 65. Buy for the long term.
Jaysynth Dyestuff manufacturer & dealer in dyes, dyes intermediates, organic chemicals, textile auxiliaries, pigments, resins, plasticizers & emulsions with low equity capital of Rs.0.9 cr. and is all set to garner an EPS of Rs. 9.5/10. Buy for the long term.
Basilic Fly Studios has a strong order book ~ Rs. 80 cr. to be executed in H1FY25, of which 75% is of FY24 total revenue.
Praveg launched Praveg Beach Resort at Nagoa Beach, Diu on May 15, featuring 31 Premium Tents and 4 dual-bedroom suites. It projects a 40-50% occupancy rate and an Average Room Rate of Rs.7,000-9,000. It is also expanding to 12 properties & developing 14 new projects.
Supreme Power Equipment secures Rs. 11.32 crore order to supply 50 MVA transformers for a solar project by Sept 2024, raising its total order book to Rs. 49.52 crore.
Praveg secures a 30-year land lease in Jawai, Rajasthan, for a luxury cave resort with 12 cave rooms, 8 tents, a pool, restaurant, bar & safari experiences, offering a blend of luxury & cultural immersion.
Wardwizard Innovations & Mobility post 135% YoY growth in EV sales of 1,071 units compared to 455 units in April 2023 with retail sales reaching 1,212 units in April 2024.
Mitsu Chem Plast currently operating at 70% of its 26,206 TPA capacity to expand by 1,800 TPA by May 2024 investing Rs. 206.5 lakh in new machinery.
BEL has a healthy order book. All it manufactures is a part of the Aatmanirbhar Bharat's programme and is expected to post a strong FY24 along with a good dividend/ bonus. Add.
Shyam Metaliks plans to establish a SS bright bars capacity of 25,000 TPA and an SS wires division with a capacity of 18,000 TPA. Add.
M&M Q4 NP rose 32% YoY to Rs.2,038 cr. and revenue grew 11% YoY. Further, it approved an investment of Rs.12,000 cr. for its EV Subsidiary. Add.
Eicher Motors’s unit, VE Commercial Vehicles signs a JV with I Triangle Info tech. A big positive. Further, it plans to launch its first electric Royal Enfield bike by 2025. Buy.
Glaxo (GSK) Q4 NP rose 46% to Rs.194.5 cr. It now plans 12 launches from 2025, which include new vaccines & medicines for HIV, oncology, respiratory diseases, etc. Add.
Dixon Technologies sees a $10 bn. IT hardware opportunity in India. Recently, it signed a MOU with Acerpure for manufacturing of consumer appliance products. A big positive. Buy.
TVS Motors plans to launch a series of products in the range of 5-25 KW by 2025. Further, it also started its operation in Italy. Add.
Infosys enters in to a multi-year pact with UAE's First Abu Dhabi Bank to optimize and modernize its IT infra. A big positive. Add.
Cochin Shipyard bags huge Rs.500-1000 cr. orders from an European client for Hybrid SOVs. Further, it also has orders worth Rs.11.54 cr. from UDUPI Cochin Shipyard Ltd. Buy.
HAL Q4 profit jumped 52% to Rs.4309 cr. YoY and revenue grew 18% YoY. Analysts are still bullish on this counter. Add for the long term.
submitted by Downtown-Database192 to NSEbets [link] [comments]


2024.05.18 16:05 Downtown-Database192 Market Updates

As per a market veteran, greed is at every level. There is greed with F&O traders, hedge funds and exchanges facing M/W/D expiry. Since greed at such expiries are natural, why blame hedge funds for our actions and losses? It is wrong to blame others for our failure to understand the risks of F&O trading. If retail investors don't know the tricks of trading, they should simply step aside and do nothing. Volatility on expiry day is a given fact. One should know how to play against the big sharks or else stay away from F&O trading. We just create excuses for our failure in understanding the terms of business and the risks involved as everyone is addicted to F&O trading despite the huge losses. It is impossible for them to control their greed. Interpreting the right direction on expiry day is a must if one has to survive the volatility in the markets.
As per a market veteran, when market is on its peak, avoid tip and rumor-based trading, as there are chances of getting trapped. Do your own research for every company you choose to invest in. Follow very strictly the single rule allocation - not more than 7-9% of the portfolio in a single stock even if the promoter says so. Do not trade if the concept of the trade is not clear in your mind. Till 4th June, there will be wild volatile swings both ways. But if you have taken a trade without having the clear concept, you will get trapped.
As per a market veteran, never sell your winners to average out your losers! Otherwise, the day is not far when you will end up having a bunch of losers only! Bull markets are like marathons. Those who run it know the importance of consistency and discipline. People expect calamities and catastrophic in steady bull markets. So invest energy to develop patience and face them. Ride the tide and don’t time the ride.
Eco Recycling, first identified by Money Times two-years back and billed as a potential multi-bagger in our Panchratna newsletter this February has posted excellent results and the stock is on its upward journey.
In our 6th Jan MTTs, Sika Interplant recommended at Rs.1395 touched Rs.2504.
In our 21st Oct MTTs, Techno Ele. recommended at Rs. 514 touched Rs.1135.
In our 11th May MTTs, RAMINFO recommended at Rs.143 touched Rs.159, DCM Shriram Ind. recommended at Rs.195 touched Rs.220, Shemaroo recommended at Rs.157 touched Rs.165, Gulshan Polyoils recommended at Rs.197 touched Rs.205.
IRB Infra Q4 PAT grew 45% to Rs.189 cr. and consolidated income rose 47% to Rs.2504 cr. It has a equity of Rs.604 cr. and reserve of Rs.13141 cr. Total aggregate payout of Rs.181 cr. towards final dividend and third interim for FY24 has been declared. Add for decent gains.
Last week, Axis MF bought 26 lakh shares of Anantraj. Keep on radar for decent gains in medium-long term.
Va Tech Wabag results will be declared on 21st May 2024, which are expected to be encouraging. Keep it on your radar.
PNC Infratech results will be declared on 24th May 2024, which are expected to be strong. Further, a health dividend is also expected. Keep it on your radar.
ITD Cementation results will be declared on 28th May 2024, which are likely to be encouraging. Further, a health dividend is also expected. Keep it on your radar.
Vibrant Global notched an EPS of Rs.17.5 in the last 6 months and trades at a P/E of 4x. Promoters hold 71.3% and renowned fund manager, Siddharth Bhaiya, holds 22.64%. Its results on 18th May 2024 are likely to be promising with a healthy dividend. Add for multi bagger gains.
Shri Bajrang Alliance caters to Jubliant Foods, Nestle, KFC & Lulu Group for exports and exports to Australia, USA, Netherlands, Middle East, UK and New Zealand. It posted 9M EPS of Rs.29.77 and trades at a P/E of 8.5x. Buy for multi-bagger gains.
Debt-free Elixir Capital posted Q4 EPS of Rs.13.55 and FY24 EPS of Rs 26.89. It trades at a P/E of 4x. Promoters hold 71.3%, HNI’s & corporates hold 15.93%. Keep it on your radar.
Himatsingka Seide results on 23rd May 2024, which are expected to be strong with a healthy dividend. Keep it on your radar.
Kabra Extrusion Q4 NP rose 450% to Rs.18.97 cr. and declared a dividend of 70%. It is the industry leader 40% market share and partners Hero MotoCorp to supply battery packs & chargers. Thus, FY25 is expected to be the best. Add for 30% gains.
PNB Q4 NP rose 159.8% to Rs.3,010 cr. from Rs.1,159 cr. YoY and 35.4% to Rs.3,010 cr. from Rs.2,223 cr. QoQ. Its FY24 NP grew 228.8% to Rs.8,245 cr. and declared a divided of 75%. Add for decent gains.
Godrej Agrovet is into animal feed, crop protection, dairy, oil palm, poultry & processed foods. Promoters hold 74%, DIIs & FIIs hold 16.3%. It posted FY24 NP of Rs.359 cr. and declared a dividend of 100%. Add for 30% gains.
HCC results on 24th May 2024 are expected to be excellent. Keep it on your radar.
Andhra Petrochemicals Q3 NP grew 923% to Rs.9.82 cr. from Rs.0.96 cr. YoY. Its tie-up with GAIL for Natural Gas will lower production cost and boost its bottom-line. It results on 25th May 2024 are expected to be strong and a healthy dividend is likely. Buy for hefty gains.
Artefact Projects has huge orders for 6 years having bagged Rs.5.50 cr. order from NHAI. It pre-paid its debt of Rs.5 cr. and trades at a P/E of 8x and P/B of 0.86x. Its Q3 NP grew 60% and 9M NP rose 53%. It results on 21st May 2024 are expected to be good. Keep it on your radar.
TVS Holdings not only holds TVS Motor shares but is also engaged in the booming real estate business. Recently, it took over an NBFC aslo. Accumulate.
Hero MotoCorp is going ultra-aggressive in the two-wheeler segment and in the stock market too. Catch it before it goes out of reach. Add.
Maruti Suzuki remains unmatched in its market share, new models, distribution reach & service excellence. The stock is likely to speed up. Accumulate.
Fineotex Chemical receives an in-principle approval from BSE & NSE for preferential issue of warrants. It is in advanced talks for acquisition of a specialty chemicals unit. Add.
JTL Industries posted its highest-ever sales volume of 3,41,846 TPA for FY24 and posted revenue of Rs.2040.2 cr. on the back of robust demand. Buy.
Cellecor Gadgets record significant growth as it broadens its reach, distribution channels & product offerings, which boosted its marketing success. Add.
One Point One Solutions FY24 revenue grew 21.44% YoY to Rs.175.16 cr., EBITDA grew 52.95% YoY to Rs.56.76 cr. and PAT grew 143.5%. Add.
Sakuma Exports announced a substantial investment of £7.1 million in its wholly-owned subsidiary, Sakuma Impex Ltd. UK., which has an order book of £5 million. Add.
Sawaca Business Machines receives strategic proposal from TCS IT Dubai to develop AI based SCM, which includes acquisition of 20-25% stake in Sawaca Business Machines. A big positive. Buy.
Gujarat Toolroom's Rs.572.5 cr. Hybrid-Green Energy Power plant is projected to generate yearly profit of Rs.145.82 cr. Add.
Univastu India into civil construction projects has a Mkt.Cap. of Rs.237 cr. and posted Q3 sale of Rs.29.93 cr. with PAT of Rs.2.49 cr. and Q4 is likely to be better. Strong growth likely amid the infra boom. Buy.
Aartech Solonics, a turnaround player in Electrical Machinery boasts record order book and expansion plans. With investments in USA & UK subsidiaries, is poised for multi-bagger returns in the fancied Defense & Power sectors. Its Q4 results on 30th May 2024 may spring a pleasant surprise to shareholders. Buy.
Rudra Global Infra Products, manufactures TMT Bars, serving top clients like L&T and Reliance. Recently doubled production capacity and launched Rudra Inframart stores. Strong growth expected amid govt.'s infra investments. Buy.
NSE SME-listed ROX Hi-Tech evolved from an IBM & Cisco Business Partner to offer comprehensive IT solutions including AI. It is expected to notch an EPS of Rs 10 in FY24. Its IPO capex of Rs 50 cr. may lead to FY25 EPS of Rs 15+. Buy for hefty gain.
Zero-debt Just Dial from Reliance fame provides local search services through various platforms such as the internet, mobile internet, over the telephone (voice) & text (SMS). It posted 37% higher Q4 EPS of Rs.13.6 and 126% higher FY24 EPS of Rs. 42.7. Buy for 25% gain.
Union Bank has clocked 54% higher FY24 EPS of Rs.19.2. Buy for 20% gain.
Sandesh, Gujarati newspaper, published from 7 centers, posted 74% higher Q3 EPS of Rs.76.2 and 28% higher 9M EPS of Rs.154.3 on small equity of Rs.7 cr., which may lead to FY24 EPS to Rs.185/190. Buy for 25% gain.
Bank of India posted 35% higher Q4 EPS of Rs.4.6 and 65% higher FY24 EPS of Rs.15.5. Buy.
Repco Home Finance posted 36% higher Q3 EPS of Rs.18.2 and 32% higher FY24 EPS of Rs.66.6, which may lead to FY25 EPS of Rs.82+ Buy for a decent gain.
Jammu & Kashmir Bank posted Q4 EPS of Rs.5.8 and FY24 EPS of Rs.6.8. The robust Q4 EPS indicates that FY25 EPS may lead to Rs.24. Buy for 25% gain.
Nile Ltd., manufacturer of Pure Lead & Lead Alloys, plans a Lithium-ion recycling plant. It posted 140% higher Q3 EPS of Rs.39.7 and 78% higher 9M EPS of Rs.84.2, which may lead to FY24 EPS to Rs.125+. Add.
Karur Vysys Bank posted 36% higher Q4 EPS of Rs.5.7 and 45% higher FY24 EPS of Rs.20. Investments in Govt securities rose 19% to Rs.22,344 cr. in FY24, which may lead to FY25 EPS of Rs.27/28. Buy for 20% gain.
NCL Industries posted 152% higher Q4 EPS of Rs.5.2 and 110% higher FY24 EPS of Rs.20.5. Buy for 25% gain.
GPIL into iron ore mining, iron ore pellets, sponge iron, steel billets, rounds & wires, silico manganese, ferroalloys, prefab galvanized with captive power plants is expected to clock an EPS of Rs. 65. Buy for the long term.
Jaysynth Dyestuff manufacturer & dealer in dyes, dyes intermediates, organic chemicals, textile auxiliaries, pigments, resins, plasticizers & emulsions with low equity capital of Rs.0.9 cr. and is all set to garner an EPS of Rs. 9.5/10. Buy for the long term.
Basilic Fly Studios has a strong order book ~ Rs. 80 cr. to be executed in H1FY25, of which 75% is of FY24 total revenue.
Praveg launched Praveg Beach Resort at Nagoa Beach, Diu on May 15, featuring 31 Premium Tents and 4 dual-bedroom suites. It projects a 40-50% occupancy rate and an Average Room Rate of Rs.7,000-9,000. It is also expanding to 12 properties & developing 14 new projects.
Supreme Power Equipment secures Rs. 11.32 crore order to supply 50 MVA transformers for a solar project by Sept 2024, raising its total order book to Rs. 49.52 crore.
Praveg secures a 30-year land lease in Jawai, Rajasthan, for a luxury cave resort with 12 cave rooms, 8 tents, a pool, restaurant, bar & safari experiences, offering a blend of luxury & cultural immersion.
Wardwizard Innovations & Mobility post 135% YoY growth in EV sales of 1,071 units compared to 455 units in April 2023 with retail sales reaching 1,212 units in April 2024.
Mitsu Chem Plast currently operating at 70% of its 26,206 TPA capacity to expand by 1,800 TPA by May 2024 investing Rs. 206.5 lakh in new machinery.
BEL has a healthy order book. All it manufactures is a part of the Aatmanirbhar Bharat's programme and is expected to post a strong FY24 along with a good dividend/ bonus. Add.
Shyam Metaliks plans to establish a SS bright bars capacity of 25,000 TPA and an SS wires division with a capacity of 18,000 TPA. Add.
M&M Q4 NP rose 32% YoY to Rs.2,038 cr. and revenue grew 11% YoY. Further, it approved an investment of Rs.12,000 cr. for its EV Subsidiary. Add.
Eicher Motors’s unit, VE Commercial Vehicles signs a JV with I Triangle Info tech. A big positive. Further, it plans to launch its first electric Royal Enfield bike by 2025. Buy.
Glaxo (GSK) Q4 NP rose 46% to Rs.194.5 cr. It now plans 12 launches from 2025, which include new vaccines & medicines for HIV, oncology, respiratory diseases, etc. Add.
Dixon Technologies sees a $10 bn. IT hardware opportunity in India. Recently, it signed a MOU with Acerpure for manufacturing of consumer appliance products. A big positive. Buy.
TVS Motors plans to launch a series of products in the range of 5-25 KW by 2025. Further, it also started its operation in Italy. Add.
Infosys enters in to a multi-year pact with UAE's First Abu Dhabi Bank to optimize and modernize its IT infra. A big positive. Add.
Cochin Shipyard bags huge Rs.500-1000 cr. orders from an European client for Hybrid SOVs. Further, it also has orders worth Rs.11.54 cr. from UDUPI Cochin Shipyard Ltd. Buy.
HAL Q4 profit jumped 52% to Rs.4309 cr. YoY and revenue grew 18% YoY. Analysts are still bullish on this counter. Add for the long term.
submitted by Downtown-Database192 to IndianStreetBets [link] [comments]


2024.05.18 15:09 NDC71334 Booking the 2024 AEW Men's Continental Classic

Context: I thought that AEW did a great job with the Continental Classic 6 months ago and I want to try to book the next one (as I imagine they will be doing this again). For this booking, I will be doing the men's continental classic in 2024. Now for this, we are changing one major thing for this tournament compared to what they did last year. The winner of this tournament will get a shot at the AEW World Championship at the Revolution PPV. The finals of the Continental Classic will take place at World's End. The world champion in this fantasy booking for around this time is Will Ospreay. All of these matches take place on episodes of Dynamite and Collision respectively (I won't book what match takes place on which network) , I'll just be booking the tournament week-to-week. Below are the competitors listed for each block.
EDIT: My first draft exceeded the character limit for a post so I will be trimming down match details
Gold Block:
Blue Block:
Scoring: Win=3 points, Draw=1 point, Loss=0 points
20-minute time limits for each match
Outside interference is prohibited! No one is allowed at ringside (breaking these rules result in a point deduction)
Gold Block: Week 1
Blue Block: Week 1
Gold Block: Week 2
Blue Block: Week 2
Gold Block: Week 3
Blue Block: Week 3
Gold Block: Week 4
Blue Block: Week 4
Gold Bock: Week 5
Blue Block: Week 5
Final Standings (Gold and Blue):
Gold Block Finals:
Blue Block Finals:
Continental Classic Finals: AEW World's End
(MJF goes on to be a heel from this and Kenny Omega will face Will Ospreay in the main event of Revolution for the AEW World Championship)
What did you think? Did you like it? Did you not like it? What did you specifically like or dislike about it? Let me know!
submitted by NDC71334 to fantasybooking [link] [comments]


2024.05.18 15:04 MGK_2 Changing Gears

OK, we are going to try to piece it together yet again. As I've stated in the past, all is conjecture but some of the things which I said in the past need realigning given the new direction the Company is taking. For a long time we've searched, but it all started in the beginning, so therefore, by definition, there must be an end. Many thanks to you my friend u/psasoffice for your help in piecing this puzzle together.
So, the time frame begins when it began, until the time it is realized or when the money runs out. Let's go back again to the summer of 2022, when share price went to $1.26, what caused that? Well to answer that, we need to go back even further.
Back in 2019, CytoDyn put out this PR CytoDyn Announces FDA Clearance to Proceed with Phase 2 Study of Leronlimab (PRO 140) and Regorafenib as a Combination Therapy for Metastatic Colorectal Cancer. Regorafenib is a small molecule tyrosine kinase inhibitor with minimal efficacy and high toxicity. As u/perrenialloser pointed out, it has plenty of side effects and really is not that functional. However, the drug manufacturer Bayer was prepared to do this Phase II Clinical Trial in patients with metastatic CRC with CytoDyn.
"The study will be conducted by lead principal investigator, John L. Marshall, M.D., Director, The Ruesch Center for the Cure of GI Cancers Frederick P. Smith Endowed Chair, Chief, Hematology and Oncology Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C."
I wasn't around at the time to know for sure, but I believe this trial was set up by Nader. Eventually, this study would be withdrawn for reasons which I am about to disclose.
In October 2021, the MD Anderson Study with Keytruda is announced.
"Nader Pourhassan, Ph.D., CytoDyn’s President and Chief Executive Officer, said, “We anticipate this study will further evaluate the immunomodulatory effects of leronlimab in the tumor microenvironment. We are excited about the possibilities for leronlimab to offer a potential new treatment option for breast cancer patients. This could be an additional indication for which we are pursuing approval for leronlimab. We are also very grateful to Dr. Scott Kelly for arranging for this study to be conducted by Dr. Jangsoon Lee, assistant professor of Breast Medical Oncology Research at The University of Texas MD Anderson Cancer Center."
Cyrus Arman comes onboard as President effective July 9, 2022. During that summer of 2022, the CYDY share price ran up as high as $1.26 per share for some unknown reason. In the past, I attributed it to NASH. I give a breakdown of my thinking here in I Tell You A Mystery. In the commotion of Cyrus' hiring and the mass fluctuations of the share price, the MD Anderson Study had already been completed and the results were looking good to those privileged enough to have been granted rights to actually see the data. Coincidentally, it was about this time that the CRC with Regorafenib was withdrawn. Hmmm, Why was this trial withdrawn? Just because the MD Anderson results looked great or because there was something even more profound and substantial built upon those results?
"We can apply the same logic in the Oncology study being run by MD Anderson using Merck's Keytruda in combination with Leronlimab. We had all been waiting to find out what had happened with the results of the MD Anderson study, and Cyrus threw us this line: "Leronlimab is currently being trialed in combination with Keytruda (pembrolizumab) in a breast cancer xenograft model in partnership with MD Anderson Cancer Center." From here, he gave us a hint of what is to come."
In his infamous 12/7/22 R&D Update: Future Development, Cyrus presented his Vision & Plan for the Company:
"17:09: And we're also still committed to HIV, but we're really looking at it more through the lens of developing longer-acting agents. And Dr. Sacha will be talking about that at the end of our discussion today.
17:21: So, within oncology, we're interested in studying what would be referred to as immunologically colder tumors. And Dr. Glück will present on what those -- what we mean by that later. But we think that these are areas where more recent advancements from checkpoint inhibitors have yet to really have a large impact in those markets. And so, we think that there's a unique opportunity based on the data we already have in some of these colder tumors to make an impact.
17:51: Within NASH, we're particularly excited about the data that we have there, and NASH will be our primary focus going forward. We'll also talk a little bit about a unique opportunity to study and look for the treatment effect of leronlimab in people living with HIV who also have NASH. And we think that we might be in a unique position to address that population."
"18:22: So, going forward, we're focusing on NASH, oncology and earlier-line HIV indications through longer-acting agents that inhibit CCR5. Again, we've already generated promising clinical signals in both NASH and oncology. And within NASH, we're exploring the opportunity to study a segment of patients of those NASH patients who are also living with HIV.
18:50: Within oncology, we want to pursue colorectal cancer and breast cancer specifically. Within the colorectal cancer population, we want to focus on a micro-satellite stable group, which represents about 85% of all diagnosed colorectal cancers. And within breast cancer, we want to focus on the hormone receptor positive HER2-negative population, which is about 70% of all diagnosed breast cancers, and the TNBC population since we have data in that space. All of these are quite large markets."
The FDA made it truly tough for Cyrus to meet his goals as the Company's main devotion was to get the hold lifted, so Rules had to be followed. Also, Cyrus unfortunately made NASH a focus and then subsequently became sick and then found himself taking a demotion. His focus really should have been on Oncology as #1 target as it finally is today. Here though is a revealing statement he made:
"...these are areas where more recent advancements from checkpoint inhibitors have yet to really have a large impact in those markets. And so, we think that there's a unique opportunity based on the data we already have in some of these colder tumors to make an impact."
Keeping that escalation in share price to $1.26 in mind, when did CA know about this data? He got the data on the MD Anderson results either before or shortly after his hire. Remember, shortly after NP was terminated, Cyrus was at CytoDyn working at least for a few months prior to his hire giving opportunity to the BOD to assess his work ethic and ways about him. In this time, CA saw the MD Anderson results and they were looking mighty good. Where are these results today? They still reside with MD Anderson. Why don't we have them right now? Too many $millions to buy it, but we saw the results and those results are the impetus for the change in gears of the Company's priorities. Surely Scott Kelly, who was responsible for securing the MD Anderson study has seen them as well.
Speculation: So, what did Cyrus do immediately once he saw those results? He negotiated a cancer play in mCRC with MD Anderson. We can try to piece this together using parts of this post.
"What also happened in August? Only the removal of the first management player who’s experience was in Negotiation and Partnerships, Brendan P. Rae. No longer any necessity for Negotiation? I guess not. As time went quickly by, without any word of what was taking place, the share price began to fall. It became uncomfortably obvious that by mid November, Recknor had been let go. He was CytoDyn's most experienced scientific, medical and managerial player for NASH, but in the game of a collaboration, anyone and everyone is a commodity and all are replaceable. On the same topic, a significant stock bonus was paid to the president in September of last year after only two months on the job. Was a deal struck? Also, our very own CMO, Scott Kelly who coined the phrase: “There are many ways to structure a partnership.“ himself gets terminated in December 2022."
Just like that bonus, (which was based on his obtaining a partnership), the short-lived share price rise also assumed that a deal had been struck. Scott Kelly was privy to the MD Anderson results just as Cyrus was. Why didn't Kelly put a deal together like Cyrus did? I don't want to diminish the fact that Kelly was wholly responsible originally for getting the MD Anderson murine study going. The fact is that a deal had been made and justifies Cyrus' bonus payment.
Proof came a year later, in October 2023 in a few posts by biloxiblues which together with everything else, in my eyes, solidifies this new theory. The price went to $1.26 because of this 100% fully funded, 200 patient Phase II mCRC combination Keytruda Clinical Trial Cyrus Arman had arranged with MD Anderson, based on the spectacular results of the MD Anderson murine study. But, as discussed in the posts by biloxi above, the BOD got in the way. This can also explain why the Regorafenib Bayer trial was withdrawn, when it became clear as day that the results of the MD Anderson study were great and a massive combination Keytruda trial was struck, but pending, unfortunately, taking second fiddle to the work of getting the hold lifted.
Through his discussions with Cyrus, biloxiblues indicates that Tanya would not compromise. She and the others on the BOD were too intently focused on following the mandates of the FDA. The FDA wasn't fooling around with the hold and CytoDyn could not make any more mistakes. Tanya was dead set on following the "Rules". The number one priority was to get off clinical hold and the FDA made it damn near impossible for CytoDyn and Cyrus. It damn near killed him. So, the BOD made the incredulous decision to walk away from Cyrus' baby, which was a fully funded mCRC combination trial with Keytruda and we learned all of that in October 2023 thanks to biloxiblues.
But this was Cyrus' Baby, and he wasn't about to let her go. Could this be why CA is still with us? After all, aren't we back to mCRC again?
Dr. Lalezari comes on board in November of 2023 and puts forth the Inflammation and Immune Activation within a very small sub-set of HIV patients. Share price bumped up and pulled back. Damn, this trial with 90 patients could cost CytoDyn near $10 million. Where does that money come from? Share price is lower after the announcement. Can't raise money with a low share price. That would consume boat loads of shares. Inflammation/Immune Activation was not working. People weren't buying it.
Cyrus Arman is witnessing everything going on, that there is no money and that it is not advancing, and it occurs to him that his baby, may not be completely abandoned altogether. No, he realizes that the hope he once had lost due to circumstance could now be found again, so he advocates in earnest for her.
He recalls Scott Kelly discussing the 12/14/21 CC with Scott Kelly Basket Trials:
"25: 25 Kelly: We are excited about the Basket Trials. I'll start by saying I just presented at San Antonio Conference December 10th. That was in results wrt mTNBC in combination with carboplatin, CCR5 positive, mTNBC and I tell you, the reason why we are excited about the Basket Trial is that they think that there is a growing acceptance that the Tumor Micro Environment is the next Frontier for Immunotherapy. And I mean this amongst practicing physicians, the academic world, probably as well as big pharma, and I think we are more advanced than this. We've been looking at the mechanism of action in the tumor micro environment and see Leronlimabs impact across multiple different oncologic indications and we also think that we can pair this with a check point inhibitor, chemo, radiation, antibody zero conjugates, as well as maybe even a potential monotherapy in certain patients that don't qualify for other treatments. We think the MOA, with T-Regs. When T-Regs come in, they turn off the immune system. We know that they have a high prevalence of CCR5. We can block that. We can actually maybe leverage the immune system. If we look at macrophage re-polarization, that's another potential opportunity. Our animal studies showed a significant reduction in angiogenesis. I think it was 62% in total vessillary and 80% reduction in small vessel area. But, we know that tumors need a blood supply to grow and if we can help limit that, then we think we can have benefit for patients. And last, we know that normal cells, CCR5 is only present on an immune cell, but we know that when cells under go malignant transformation, that they start sprouting up CCR5, and we believe that is a contributor to metastasis. So, we have multiple different mechanisms of action and we continue to find more as we go along that we will be evaluating."
He remembers Dr. Gluck's discussion in the 12/7/22 R&D Update Dr. Stefan Gluck; MicroEnvironment.
"So, as you saw, very small studies, but extremely promising, and the signal for an oncologist like myself is so strong that I'm enthusiastic about it. We, as oncologists, need to be positive because otherwise, we cannot treat patients and tell them something better is coming. The leronlimab decrease of these tumor cells actually did relate both in mTNBC and in colorectal with improved survival. That's amazing."
Cyrus turns to our 3rd party AI collaborator and requests an assessment on the effect of a CCR5/L5 axis blockade in mCRC. Their AI engines get to work and compile all that is known and understood regarding the pertinent Biomarkers in combination with all the pertinent journal articles on the blockade of the CCR5/L5 axis in the disease to finally determine that it works like a charm, like no other.
He reflects upon these statements made in this Regorafenib study which supports the fight against the MSS cold tumors. Thank you u/perrenialloser for this journal article.
"The majority of patients with CRC exhibit a microsatellite stable (MSS) or mismatch repair proficient (pMMR) status, which is known as the “cold tumor” with less mutated oncogenes and less inflamed tumor immune microenvironment, resulting in a limited efficacy of ICIs (2). The inadequate recruitment and activization of immune cells to the tumor microenvironment were considered to be fundamental mechanisms underlying the inefficacy of ICIs in MSS mCRC (4). Combination strategies to enhance the immunogenicity of the tumor microenvironment and exploit the benefit of ICIs in patients with MSS are urgently needed."
He becomes even more convicted. Given all that I presented here in addition to the proven results of the MD Anderson, Keytruda study which Cyrus has laid his own eyes upon, he becomes whole heartedly supportive of the Priority switch to the mCRC Oncology Indication. I'm sure Richard Pestell was also 100% behind Cyrus in this decision to switch priorities. Also, by switching to Oncology, share price has a better chance of increasing as Oncology is favored by the public. Fund raising could happen much quicker with a higher share price resulting from a better indication. From the recent May 2024 Letter to Shareholders:
"Over the next six months, we expect to commence at least one, and potentially two clinical trials. The prospective clinical trials, in order of priority, are: (i) a Phase II study of leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer; and (ii) a Phase II study exploring leronlimab’s effects on inflammation. The Company’s priority will be the oncology trial which, if successful, will put us on track towards a commercial approval of leronlimab in that indication. The inflammation study is aimed at clarifying certain provocative observations related to leronlimab, and to help define the dose and underlying mechanism of anti-inflammatory action. It is imperative that the Company generate unassailable results in the clinic and I believe the above trials can accomplish this. Starting the oncology study and related fundraising is the top priority of the Company at this time, but our current hope is that we can initiate both studies before the end of this calendar year."
So straight from the CEO's mouth, related fundraising is the top priority of the Company at this time. Cyrus remains here at CytoDyn because of the need to pump up the value by switching to a more attractive Indication Priority. I repeat all of this, because with all of the peer reviewed and published Journal Articles that discuss the CCR5/L5 axis in the context of Colo-Rectal Cancer and given Keytruda's exceptional performance as a PD 1 blockade in only 15% of these CRC MSI tumors, leronlimab can open the door wide open to the remaining 85% MSS tumors. The trial starts this year. Also from the recent Shareholder Letter:
"Research and development partnership opportunities are important to the Company as we search for cost-effective ways to further build out our product development portfolio. We have identified several such opportunities that we believe are intriguing and anticipate finalizing agreements with these partners in the very near future. Such potential partnerships include an investigator-initiated pilot study of leronlimab in patients with Alzheimer’s Disease, and a project that will evaluate the use of leronlimab in patients living with HIV who are undergoing stem cell transplantation in a proof of cure study. Following lifting of the clinical hold, we have observed a significant increase in third parties that are interested in partnering with the Company. We will continue to review opportunities as they arise, given the potential for significant value return at little or no cost to the Company."
The question I now have is with whom? Partners are incoming, but did leronlimab make it easier for the PD-1 blocker Keytruda to work in MSS mCRC tumors? If it did, (and Cyrus knows if it did or did not), then Merck certainly remains there in the bidding. If leronlimab did it all by itself and Keytruda was superfluous, then the partner might be someone like u/i__OBSERVER points to entities such as the NIH as the source of that funding.
Personally, I am very much thankful to anyone involved that pushed for the change in priority as mCRC is a much better recognized Indication, and one that is easier to understand and bring to the public.
submitted by MGK_2 to Livimmune [link] [comments]


2024.05.18 14:36 MidasTouch6 Turning the Ship

It seems they’ve done very little right.
The Polestar 2 is a rehashed Volvo S60, the 3 a Volvo 90 and the 4 a Zeeker, Geely variant. Surely the costs to put a Polestar skin on these was minimal?
Why have they spent so much money? They have no manufacturing or assets??
If you were joining tomorrow as Chairman what would your next moves be.
Here’s mine:
  1. Put Thomas into a head of design role
  2. Get in a serious CEO from the motor industry
  3. Sell the 2 in its LR single motor variant fully loaded for 3K more than the Tesla Model 3
  4. Close down all Polestar spaces and move to a dealership model globally with preference given to Volvo dealers who will also service
  5. Halt indefinitely the 5 and 6 which are distractions and won’t contribute to the bottom line. These are luxury prestige cars, a brand that is seen to be failing won’t have appeal to this segment. Polestar can return to this segment when things improve
  6. Get some of the cars onto racing circuits with YouTube influencers to emphasise racing heritage
  7. Design and launch a volume offering, a Golf, BMW 1 Series sized car at a 15% premium to the MG 4
  8. Pause indefinitely all ancillary efforts around Carbon Zero, Fashion sponsorships, LGBT, Tree Houses, Speedboats or any other nonsense distractions
  9. A shelf offering to raise $1.5Bn and a 20 to 1 reverse split (this will be popular here buts vital for survival)
  10. Stop all advertising other than Google ad words and working with YouTube influencers
Profitability by 2025 is now a pipe dream. Polestar is in survival mode now.
submitted by MidasTouch6 to PSNY_Polestar_SPAC [link] [comments]


http://rodzice.org/